DCP Holding 10-K 20 Mar 15 2014 FY Annual report Financial data

Document_And_Entity_Informatio

Document And Entity Information (USD $)	12 Months Ended
	Dec. 31, 2014	Jun. 30, 2014	Mar. 06, 2015
Document Information [Line Items]
Entity Registrant Name	DCP Holding CO
Document Type	10-K
Current Fiscal Year End Date	-19
Entity Public Float		$7,500,000
Amendment Flag	FALSE
Entity Central Index Key	1361025
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Non-accelerated Filer
Entity Well-known Seasoned Issuer	No
Document Period End Date	31-Dec-14
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	FY
Class A Redeemable Common Shares [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding			537
Class C Redeemable Common Shares [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding			0
Class B Redeemable Common Shares [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding			7,678

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Dec. 31, 2014	Dec. 31, 2013
INVESTMENTS:
Fixed maturities, available for sale at fair value, amortized cost of $7,397,000 and $6,986,000 at December 31, 2014 and 2013, respectively	$7,547,366	$7,068,365
Short-term investments, available for sale at fair value, cost of $700,000 and $260,000 at December 31, 2014 and 2013, respectively	704,676	261,244
Total investments	8,252,042	7,329,609
CASH AND CASH EQUIVALENTS	9,189,994	8,105,859
ACCRUED INVESTMENT INCOME	69,462	53,287
ACCOUNTS RECEIVABLE, including uncollected premiums of $1,021,970 and $719,755, net of allowance of $13,488 and $7,686 at December 31, 2014 and 2013, respectively	32,576,154	34,530,021
DEFERRED ACQUISITION COSTS	2,050,328	2,190,462
PROPERTY AND EQUIPMENT, net of depreciation and amortization of $2,968,846 and $2,728,361 at December 31, 2014 and 2013, respectively	2,676,914	2,473,285
OTHER ASSETS	2,423,916	2,220,582
TOTAL ASSETS	57,238,810	56,903,105
CLAIMS PAYABLE	2,997,613	2,219,725
UNEARNED PREMIUM REVENUE	32,636,768	35,395,337
OTHER PAYABLES AND ACCRUALS	5,444,808	5,445,258
MORTGAGE LOAN PAYABLE	1,247,600	1,294,400
CAPITAL LEASE OBLIGATION	771,478	379,265
DEFERRED COMPENSATION	2,766,449	2,062,783
TOTAL LIABILITIES	45,864,716	46,796,768
COMMITMENTS AND CONTINGENCIES
REDEEMABLE PREFERRED AND COMMON SHARES:
Total redeemable preferred and common shares	11,374,094	10,106,337
TOTAL LIABILITIES, REDEEMABLE SHARES AND SHAREHOLDERS’ EQUITY	57,238,810	56,903,105
Institutional Preferred Shares-2010 Series [Member]
REDEEMABLE PREFERRED AND COMMON SHARES:
Redeemable shares	414,173	391,814
Institutional Preferred Shares-2012 Series [Member]
REDEEMABLE PREFERRED AND COMMON SHARES:
Redeemable shares	1,195,484	1,130,946
Institutional Preferred Shares-2013 Series [Member]
REDEEMABLE PREFERRED AND COMMON SHARES:
Redeemable shares	1,099,604	1,040,242
Class A Redeemable Common Shares [Member]
REDEEMABLE PREFERRED AND COMMON SHARES:
Redeemable shares	529,158	488,282
Class B Redeemable Common Shares [Member]
REDEEMABLE PREFERRED AND COMMON SHARES:
Redeemable shares	7,815,789	7,055,053
Class C Redeemable Common Shares [Member]
REDEEMABLE PREFERRED AND COMMON SHARES:
Redeemable shares	319,886
Class D Redeemable Common Shares [Member]
REDEEMABLE PREFERRED AND COMMON SHARES:
Redeemable shares	0	0
Provider Preferred-2009 Series [Member]
REDEEMABLE PREFERRED AND COMMON SHARES:
Redeemable shares	$0	$0

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parentheticals) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Fixed maturities, available for sale at fair value, amortized cost (in Dollars)	$7,397,000	$6,986,000
Short-term investments, available for sale at fair value, amortized cost (in Dollars)	700,000	260,000
Accounts receivable, uncollected premiums (in Dollars)	1,021,970	719,755
Accounts receivable, allowance (in Dollars)	13,488	7,686
Depreciation and amortization, property and equipment (in Dollars)	$2,968,846	$2,728,361
Redeemable preferred shares, authorized	92,700	92,700
Redeemable preferred shares, issued	0	0
Redeemable preferred shares, par value (in Dollars per share)	$0	$0
Institutional Preferred Shares-2010 Series [Member]
Redeemable preferred shares, cumulative dividend rate	5.00%	5.00%
Redeemable preferred shares, authorized	300	300
Redeemable preferred shares, issued	300	300
Redeemable preferred shares, outstanding	300	300
Redeemable preferred shares, par value (in Dollars per share)	$0	$0
Institutional Preferred Shares-2012 Series [Member]
Redeemable preferred shares, cumulative dividend rate	5.00%	5.00%
Redeemable preferred shares, authorized	1,000	1,000
Redeemable preferred shares, issued	1,000	1,000
Redeemable preferred shares, outstanding	1,000	1,000
Redeemable preferred shares, par value (in Dollars per share)	$0	$0
Institutional Preferred Shares-2013 Series [Member]
Redeemable preferred shares, cumulative dividend rate	5.00%	5.00%
Redeemable preferred shares, authorized	1,000	1,000
Redeemable preferred shares, issued	1,000	1,000
Redeemable preferred shares, outstanding	1,000	1,000
Redeemable preferred shares, par value (in Dollars per share)	$0	$0
Class A Redeemable Common Shares [Member]
Redeemable common shares, par value (in Dollars per share)	$0	$0
Redeemable common shares, authorized	7,500	7,500
Redeemable common shares, issued	531	546
Redeemable common shares, outstanding	531	546
Class B Redeemable Common Shares [Member]
Redeemable common shares, par value (in Dollars per share)	$0	$0
Redeemable common shares, authorized	120,000	120,000
Redeemable common shares, issued	7,843	7,889
Redeemable common shares, outstanding	7,843	7,889
Class C Redeemable Common Shares [Member]
Redeemable preferred shares, authorized	80,000	80,000
Redeemable preferred shares, issued	321	0
Redeemable preferred shares, outstanding	321	0
Redeemable preferred shares, par value (in Dollars per share)	$0	$0
Class D Redeemable Common Shares [Member]
Redeemable preferred shares, authorized	100,000	100,000
Redeemable preferred shares, issued	0	0
Redeemable preferred shares, par value (in Dollars per share)	$0	$0
Provider Preferred-2009 Series [Member]
Redeemable preferred shares, cumulative dividend rate	5.00%	5.00%
Redeemable preferred shares, authorized	5,000	5,000
Redeemable preferred shares, issued	0	0
Redeemable preferred shares, par value (in Dollars per share)	$0	$0

Consolidated_Statements_of_Com

Consolidated Statements of Comprehensive Income (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
REVENUES
Premium revenue	$91,936,578	$86,362,613	$80,153,437
Investment income	221,622	164,057	128,412
Realized gains on investments	29,691		34,046
Other income	62,304	61,477	67,926
Total revenues	92,250,195	86,588,147	80,383,821
EXPENSES
Healthcare services expense	71,695,797	67,762,332	63,735,583
Insurance expense:
Salaries and benefits expense	7,249,590	6,534,300	5,523,969
Commission expenses and other acquisition costs	5,123,790	4,074,714	3,879,603
Other insurance expense	5,952,103	6,180,356	5,206,212
Total insurance expense	18,325,483	16,789,370	14,609,784
Total expenses	90,021,280	84,551,702	78,345,367
INCOME BEFORE INCOME TAX	2,228,915	2,036,445	2,038,454
PROVISION (BENEFIT) FOR INCOME TAX:
Current	1,039,777	825,242	993,464
Deferred	-152,035	-70,403	-273,027
INCOME TAX EXPENSE	887,742	754,839	720,437
NET INCOME	1,341,173	1,281,606	1,318,017
OTHER COMPREHENSIVE INCOME (LOSS), NET OF TAX
Change in the fair value of interest rate swap, net of income tax of $17,260, ($4,877), and ($10,479), respectively	33,504	-9,466	-20,342
Change in the fair value of investments, net of income tax of $33,974, ($56,513), and $73,856, respectively	65,943	-109,695	143,369
Reclassification adjustment for gains included in net income, net of tax of ($10,095) and ($11,697), respectively	-19,596		-22,708
Total other comprehensive income (loss)	79,851	-119,161	100,319
TOTAL COMPREHENSIVE INCOME	$1,421,024	$1,162,445	$1,418,336

Consolidated_Statements_of_Com1

Consolidated Statements of Comprehensive Income (Parentheticals) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Interest rate swap, tax expense (benefit)	$17,260	($4,877)	($10,479)
Investments, tax expense (benefit)	33,974	-56,513	73,856
Reclassification adjustment for gains included in net income, net of tax	($10,095)		($11,697)

Consolidated_Statements_of_Red

Consolidated Statements of Redeemable Shares and Shareholders’ Equity (USD $)	Class A Redeemable Common Shares [Member]	Class B Redeemable Common Shares [Member]	Class C Redeemable Common Shares [Member]	Institutional Preferred Shares-2010 Series [Member]	Institutional Preferred Shares-2010 Series [Member]	Institutional Preferred Shares-2012 Series [Member]	Institutional Preferred Shares-2013 Series [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Total
	Common Stock [Member]	Common Stock [Member]	Preferred Stock [Member]	Preferred Stock [Member]		Preferred Stock [Member]	Preferred Stock [Member]
Balance at Dec. 31, 2011
Net Income								$1,318,017		$1,318,017
Other comprehensive income (loss), net									100,319	100,319
Dividends declared					67,000			-244,103		-244,103
Redeemable Shares issued	812	169,335				1,000,000
Redeemable Shares issued (in Shares)	1	214				1,000
Class A Common Shares exchanged for Class B Commons Shares	-9,819	9,819
Class A Common Shares exchanged for Class B Commons Shares (in Shares)	-14	14
Redeemable Shares repurchased	-13,649	-212,956
Redeemable Shares repurchased (in Shares)	-18	-285
Accretion of shares to redemption value	74,075	990,094		31,279		78,785		-1,073,914	-100,319	-1,174,233
Balance at Dec. 31, 2012	460,630	6,334,675		373,743		1,078,785
Balance (in Shares) at Dec. 31, 2012	565	7,770		300		1,000
Net Income								1,281,606		1,281,606
Other comprehensive income (loss), net									-119,161	-119,161
Dividends declared					123,000			-392,196		-392,196
Redeemable Shares issued		322,481					1,000,000
Redeemable Shares issued (in Shares)		376					1,000
Class A Common Shares exchanged for Class B Commons Shares	-5,672	5,672
Class A Common Shares exchanged for Class B Commons Shares (in Shares)	-7	7
Redeemable Shares repurchased	-9,998	-224,228
Redeemable Shares repurchased (in Shares)	-12	-264
Accretion of shares to redemption value	43,322	616,453		18,071		52,161	40,242	-889,410	119,161	-770,249
Balance at Dec. 31, 2013	488,282	7,055,053		391,814		1,130,946	1,040,242			10,106,337
Balance (in Shares) at Dec. 31, 2013	546	7,889		300		1,000	1,000
Net Income								1,341,173		1,341,173
Other comprehensive income (loss), net									79,851	79,851
Dividends declared					128,000			-425,327		-425,327
Redeemable Shares issued		290,468	305,212
Redeemable Shares issued (in Shares)		290	321
Redeemable Shares repurchased	-13,834	-309,786
Redeemable Shares repurchased (in Shares)	-15	-336
Accretion of shares to redemption value	54,710	780,054	14,674	22,359		64,538	59,362	-915,846	-79,851	-995,697
Balance at Dec. 31, 2014	$529,158	$7,815,789	$319,886	$414,173		$1,195,484	$1,099,604			$11,374,094
Balance (in Shares) at Dec. 31, 2014	531	7,843	321	300		1,000	1,000

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$1,341,173	$1,281,606	$1,318,017
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	335,230	360,024	288,261
Loss on disposal of property		56,495
Realized gains on investments	-29,691		-34,046
Deferred income (benefit) tax	-152,035	-70,403	-273,027
Deferred compensation	959,380	675,195	542,630
Effects of changes in operating assets and liabilities:
Accrued investment income	-16,175	-20,369	6,746
Accounts receivable	1,953,867	-15,448,515	2,705,060
Deferred acquisition costs	140,134	-1,006,049	223,801
Other assets	-104,083	-195,397	-1,018
Claims payable	777,888	83,715	-665,458
Unearned premium revenue	-2,758,569	15,603,161	-2,664,626
Other payables and accruals	109,840	1,376,415	-84,275
Net cash provided by operating activities	2,556,959	2,695,878	1,362,065
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of investments	-2,629,082	-4,174,475	-1,166,660
Sales and maturities of investments	1,802,603	1,089,504	1,075,042
Acquisition of property and equipment	-530,245	-600,844	-124,222
Proceeds from the sale of property and equipment	516,394	311,955
Investment, other	-5,000	-5,000	-40,000
Net cash used in investing activities	-845,330	-3,378,860	-255,840
CASH FLOWS FROM FINANCING ACTIVITIES:
Mortgage loan repayments	-46,800	-45,600	-780,000
Borrowing of mortgage loan			1,340,000
Repayment of capital lease	-124,181	-137,049	-107,753
Repurchase of redeemable shares	-361,721	-264,031	-137,891
Redeemable shares issued	330,535	1,096,959	1,044,245
Dividends paid	-425,327	-392,196	-260,426
Repayment of revolving note			-650,000
Net cash (used in) provided by financing activities	-627,494	258,083	448,175
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	1,084,135	-424,899	1,554,400
CASH AND CASH EQUIVALENTS—Beginning of year	8,105,859	8,530,758	6,976,358
CASH AND CASH EQUIVALENTS—End of year	9,189,994	8,105,859	8,530,758
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for interest	59,000	56,000	46,000
Cash paid for income taxes	1,270,000	540,000	1,110,000
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Redeemed common shares (in other payables and accruals)	82,518	130,219	160,024
Capital lease obligation	516,394	405,128
Redeemable common shares issued in lieu of cash payment of deferred compensation	255,714	225,522	125,902
Deferred restricted shares units issued in lieu of cash dividend	40,712	52,042	28,210
Class A redeemable common shares exchanged for Class B redeemable common shares		5,672	9,819
Purchased property and equipment (included in other payables and accruals)	$1,344	$13,169	$26,338

Note_1_General_Information_and

Note 1 - General Information and Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]	1. GENERAL INFORMATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	DCP Holding Company (the “Company”) is the parent holding company of three wholly-owned subsidiaries which include Dental Care Plus, Inc., an Ohio corporation, Insurance Associates Plus, Inc., an Ohio corporation, and Adenta, Inc., a Kentucky corporation. The Company is primarily owned and controlled by dentists who participate in one or more of the networks that offers Dental Care Plus products. The Company is also partially owned by retired dentists, Company board members, non-dentist individuals and employees who hold voting redeemable common shares and by institutional investors that hold non-voting redeemable preferred shares. The Company primarily offers to employer groups of all sizes dental health maintenance organization (“HMO”), participating provider organization (“PPO”) and indemnity benefit plans and vision benefit plans. As of December 31, 2014, we had approximately 307,000 members in our dental benefits plans and approximately 28,900 members in our vision benefit plans. We had 2,808 dentists participating in our dental HMO network and 3,047 dentists participating in our dental PPO network at this time. The Company has a network leasing agreement with a national dental network management company that has one of the largest networks of dentists under contract in the United States. With this network leasing agreement, the Company’s dental PPO members have access to approximately 2,500 additional dentists in the Company’s operating territory and approximately 42,700 additional dentists throughout the United States. The Company also has a network leasing arrangement with a national dental administration company for the dental PPO plans that it offered on the Ohio exchange in 2014. With this network leasing arrangement, exchange members have access to approximately 1,600 dentists in Ohio.
	Dental Care Plus Inc. is an Ohio-domiciled insurance company dually licensed as a life and health insurer and a specialty health insuring corporation and able to underwrite dental indemnity, dental PPO, dental HMO, and vision benefit products as well as other life and health insurance products.
	The accounting policies of the Company conform to accounting principles generally accepted in the United States of America (“GAAP”). The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The accompanying consolidated financial statements include estimates for items such as claims payable, deferred acquisition costs, income taxes and various other liability accounts. Actual results could differ from those estimates. Policies that affect the more significant elements of the consolidated financial statements are summarized below.
	Basis of Presentation— The accompanying consolidated financial statements include the accounts of the Company and subsidiaries, each of which is wholly-owned, and have been prepared in conformity with GAAP. All intercompany accounts and balances have been eliminated in consolidation. The Company presents its financial statements to conform with Article 7 of the Securities and Exchange Commission Regulation S-X pursuant to Section 13-15(d) of the Securities Exchange Act of 1934.
	Cash and Cash Equivalents— The Company defines cash as cash held in operating accounts at financial institutions. The Company considers highly liquid investments with maturities of three months or less at the date of acquisition as cash equivalents in the accompanying consolidated financial statements. These investments are carried at cost, which approximates fair value.
	Investments—The Company invests in certificates of deposit, corporate bonds and money market funds. The Company classifies all investments as available-for-sale. The Company engages a fixed income portfolio manager to manage the Company’s investment grade and non-investment grade corporate bonds, under the Company’s direction, in order to maximize investment returns. Such investments are recorded at fair value, with unrealized gains and losses recorded as a component of other comprehensive income. The Company recognizes gains and losses when these securities have other than temporary impairment, mature or are sold using the specific identification method.
	Management follows a consistent and systematic process for recognizing impairments on securities that sustain other-than-temporary declines in value. The decision to record an other-than-temporary impairment for a security incorporates both quantitative criteria and qualitative information. The Company considers the severity of the loss on a security, duration of loss, duration of the investment, credit rating of the security, as well as payment performance and the Company’s intent or requirement to sell the investment before recovery when determining whether any impairment is other than temporary. The Company’s impairment policy for fixed-maturity securities states that other-than-temporary impairment is considered to have occurred if (1) the Company intends to sell the impaired fixed maturity security; (2) it is more likely than not that the Company will be required to sell the fixed maturity security before recovery of its amortized cost basis; or (3) the present value of the expected cash flows is not sufficient to recover the entire amortized cost basis.
	Property and Equipment— Property and equipment is carried at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets. The building and the building improvements have useful lives of 27 years and 15 years, respectively. Furniture and fixtures have useful lives of 5 years, and computer equipment and software have useful lives of up to 5 years. Maintenance and repair costs are expensed as incurred. If an impairment exists, a loss is recorded as the amount by which the carrying value of the asset exceeds its fair value.
	The Company reviews property and equipment for impairment whenever events or changes in circumstances, such as significant decreases in market values of assets, changes in legal factors or in the business climate, and accumulation of costs significantly in excess of the amount originally expected to acquire or construct an asset, or other such factors indicate that the carrying amount may not be recoverable.
	State Guarantee Fund Deposits— The Company maintains funds on deposit with state insurance departments in those states where the Company is licensed to do business. These funds amounted to approximately $279,000 and $280,000 at December 31, 2014 and 2013, respectively. These funds are restricted and not available to the Company for normal operations and are included in other assets in the accompanying consolidated balance sheets.
	Goodwill and Intangible Assets— Goodwill arises in business combinations when the purchase price of net assets less liabilities assumed acquired exceeds the fair value. As with tangible and other intangible assets, periodic impairment reviews are required, at least annually, as well as when events or circumstances change. Management uses judgment in assessing goodwill for impairment. Management reviews the recorded value of our goodwill annually, or sooner if events or changes in circumstances indicate that the carrying amount may exceed fair value. Professional judgment is exercised in determining future cash flows, timing and business valuation comparables or selecting discount rates to be used in any valuation assessments.
	Business acquisitions often result in recording identifiable intangible assets. Identifiable intangible assets are recognized at the time of an acquisition, based upon their fair value. Similar to long-lived tangible assets, identifiable intangible assets are subject to amortization and periodic impairment reviews whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The review for impairment of the Company’s intangible assets requires management to predict the estimated cash flows that will be generated by the long-lived asset over its remaining estimated useful life.
	Deferred Acquisition Costs— Deferred acquisition costs are those incremental direct costs related to the successful acquisition of new and renewal business. These incremental direct costs are those that are essential to the contract transaction and would not have been incurred had the contract transaction not occurred. Such incremental direct costs include commissions, costs of contract issuance and underwriting, premium taxes and other costs the Company incurs to acquire successful new business or renew existing business. The Company defers policy acquisition costs and amortizes them over the estimated life of the contracts, which are short-duration in nature, in proportion to premiums earned. The Company capitalized deferred acquisition costs of approximately $3,989,000, $4,867,000, and $3,368,000, and amortized approximately $4,129,000, $3,862,000, and $3,592,000 of these capitalized costs for the years ended December 31, 2014, 2013, and 2012, respectively. The amortization of these costs are recorded in commission expenses and other acquisition costs included in the consolidated statements of comprehensive income.
	Redeemable Institutional Preferred Shares— In 2010, the Company entered into a Preferred Stock Purchase Agreement (the “2010-Stock Purchase Agreement”) with an investor. Pursuant to the 2010-Stock Purchase Agreement, the investor agreed to purchase 300 Shares at a purchase price of $1,000 per share, with an aggregate purchase price of $300,000. The annual dividend payable on each Share is 5% of the book value at the beginning of the dividend period.
	In 2012, the Company entered into a Preferred Shares Purchase Agreement (the “2012-Stock Purchase Agreement”) with an investor. Pursuant to the 2012-Stock Purchase Agreement, the investor agreed to purchase 1,000 shares of Redeemable Institutional Preferred Shares (the “2012 Preferred Shares”) at a purchase price of $1,000 per share, for an aggregate purchase price of $1,000,000. The annual dividend payable on each 2012 Preferred Share is 5% of the book value at the beginning of the dividend period.
	In 2013, the Company entered into a Preferred Shares Purchase Agreement (the “2013-Stock Purchase Agreement”) with an investor. Pursuant to the 2013-Stock Purchase Agreement, the investor agreed to purchase 1,000 shares of Redeemable Institutional Preferred Shares (the “2013 Preferred Shares”) at a purchase price of $1,000 per share, for an aggregate purchase price of $1,000,000. The annual dividend payable on each 2013 Preferred Share is 5% of the book value at the beginning of the dividend period.
	In the event of any liquidation, dissolution or winding up of the Company, any merger or consolidation resulting in a change of control of the Company, or any sale, lease, transfer or other disposition of substantially all of the assets of Company, holders of the Institutional Preferred Shares purchased pursuant to the 2012 and 2013-Stock Purchase Agreements will have the right to receive a cash payment in an amount equivalent to the consideration the investor would have otherwise received if the investor had the ability to convert each Preferred Share to 1.2 Class B Common Shares.
	Redeemable Institutional Preferred Shares are participating securities that share in total comprehensive income as a change to the redemption value of the redeemable Institutional Preferred Shares to accrete (dilute) the carrying value to the redemption value at the end of each reporting period. Under this method, the end of the reporting period is treated as if it were also the redemption date for the securities. Redeemable Institutional Preferred Shares are considered to be redeemable shares due to the fact that the shareholders have the option to require the Company to repurchase these shares upon the shareholder’s discretion.
	Redeemable Common Shares— The Company’s Class A, Class B, and Class C redeemable common shares are owned by participating providers, Company directors, employees and non-dentist individuals. All participating providers, Company directors and Company employees are eligible to own the Class A and Class B voting redeemable common shares. Non-dentist individuals are eligible to own the Class C voting redeemable common shares. The maximum percentage of Class C Common Shares outstanding at any time as a proportion of all voting Common Shares is 40%. The Company’s Class A, Class B and Class C common shares are considered to be redeemable common shares due to the fact that the shareholders have the option to require the Company to repurchase these shares under certain circumstances. The Company records Class A, Class B and Class C common shares as Redeemable Common Shares in the consolidated balance sheets outside of shareholders’ equity at the redemption value of the common shares. Accordingly, the Company records total comprehensive income as a change to the redemption value of the Redeemable Common Shares to accrete (dilute) the carrying value of the Redeemable Common Shares to the redemption value at the end of each reporting period.  Under this method, the end of the reporting period is treated as if it were also the redemption date for the securities.
	Premium Revenue—
	Fully-Insured—Membership contracts are written on an annual basis and are subject to cancellation by the employer group upon thirty days written notice. The Company’s unearned premium revenue was approximately $32,637,000 and $35,395,000 at December 31, 2014 and 2013, respectively, and primarily relates to the estimated premium revenue associated with the remaining contract periods. Related amounts recorded in accounts receivable were approximately $31,554,000 and $33,810,000 at December 31, 2014 and 2013, respectively. Premiums are due monthly in advance and are recognized evenly as revenue during the period in which the Company is obligated to provide services to members. Any amounts not received by the end of a reporting period are recorded as accounts receivable by the Company. Any premiums received prior to the beginning of a reporting period are recognized as premiums received in advance and are included in unearned premium revenue in the accompanying consolidated balance sheets. Premiums received in advance were approximately $1,083,000 and $1,585,000 at December 31, 2014 and 2013, respectively. Management has determined that as of December 31, 2014 and 2013, respectively, no premium deficiency reserve is required. The Company’s premium deficiency reserve analysis includes an allocation of investment income.
	Self-Insured—The Company provides administrative and claims processing services, benefit plan design, and access to its provider networks for an administrative fee to self-insured groups. The Company has no underwriting risk arising from the provision or cost of any services provided to the self-insured groups. The Company recognizes and records self-insured premiums on a gross basis because: (i) the Company is the primary obligor in its contractual relationships with self-insured employers and dental service providers, (ii) the Company establishes the pricing for the services provided, (iii) the Company controls the selection of and the relationships with the dental service providers, and (iv) the Company is involved in the determination of dental service specifications. Self-insured premium revenue is recognized upon the payment of claims for self-insured members in accordance with agreements with self-insured employers and is included in premium revenue in the accompanying condensed consolidated statements of comprehensive income.
	Third-party administration fee revenue (“ASO fees”) is recognized monthly when earned and is normally based on annual contracts with the self-insured groups. ASO fees are charged to self-insured employer groups monthly on a per subscriber per month basis. ASO fees also include the administrative fees the Company earns relative to the dental PPO, dental indemnity and vision products that are underwritten by third-party insurance carriers.
	Investment Income— Investment income is comprised of interest income primarily earned from the Company’s certificates of deposit, investment grade corporate bonds, non-investment grade corporate bonds, and money market investments.
	Other Income and Realized Gains On Investments, Net — Other income is comprised primarily of rental income from the rental of space in the building owned and partially occupied by the Company (See Note 15).  Realized gains on investments is primarily made up of realized investment gains and losses from the sale of investment grade and non-investment grade corporate bonds.
	Healthcare Services Expense— Healthcare services expense is recognized on a monthly basis. In the case of the fully-insured dental HMO and indemnity (“dental HMO/IND”) and dental PPO segments, healthcare services expense is calculated by taking the paid claims associated with the fully-insured membership and adjusting this amount for the change in the claims payable liability determined using actuarial estimates. For the self-insured dental segment, the healthcare services expense is based solely on the paid claims for the self-insured membership. The Company incurred claim costs related to dental care providers amounting to approximately $71,696,000, $67,762,000, and $63,736,000, for the years ended December 31, 2014, 2013, and 2012, respectively.
	Claims Payable— The Company estimates liabilities for both incurred but not reported (“IBNR”) and reported claims in process by employing actuarial methods that are commonly used by health insurance actuaries. These estimates meet actuarial standards of practice and are also recorded in accordance with GAAP. Management’s estimates of dental services provided are based on the Company’s historical experience and current trends, with assistance from the Company’s consulting actuary. Estimated dental claims payable are reviewed monthly by management and are adjusted based on current information, actual paid claims data, dental utilization statistics and other pertinent information. However, final claim payments may differ from the established reserves. Any resulting adjustments are reflected in current operations in the condensed consolidated statements of comprehensive income.
	Reinsurance— In the normal course of business, the Company assumes premium revenue and related healthcare services expense from a third party insurance provider. There was no dental insurance premium assumed for the year ended December 31, 2014. Dental insurance premium assumed was approximately $38,000 and $189,000, for the years ended December 31, 2013 and 2012, respectively. There was no healthcare services expense assumed for the year ended December 31, 2014. The healthcare services expense assumed was approximately $28,000 and $173,000 for the years ended December 31, 2013 and 2012, respectively. As of December 31, 2014, the Company had no reinsurance premium receivable or claims payable. As of December 31, 2013, the Company had approximately $1,000 of reinsurance premium receivable and claims payable of approximately $1,000.
	Derivative Instruments— All derivative financial instruments are recorded on the consolidated balance sheet at fair value. The changes in fair value of derivatives that are designated and qualify as cash flow hedges are recorded in other comprehensive income, with subsequent reclassification to earnings when the hedged transaction asset or liability impacts earnings. Any ineffectiveness is recognized in earnings immediately. The Company’s risk management policy is to not enter into derivatives for speculative purposes.
	Federal Income Tax— Deferred federal income tax is provided for in the accompanying consolidated financial statements for the tax effects of temporary differences between the carrying values and tax bases of assets and liabilities. Differences result primarily from items such as accrued commissions, deferred compensation, unearned premiums, property and equipment, deferred acquisition costs and unrealized gains on investments.
	The Company reviews the deferred tax assets to determine the necessity of a valuation allowance. Valuation allowances are provided to the extent it is more likely than not that deferred tax assets will not be realized. The Company files a consolidated federal income tax return which includes all subsidiaries.
	Concentrations of Credit Risk— Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of premiums receivable. Other than as discussed below, concentrations of credit risk with respect to premiums receivable are limited because of the large number of employer groups comprising the Company’s client base and contracts are cancelled if premiums are not paid within 90 days.
	During 2014, 2013, and 2012, four fully-insured customers accounted for approximately 9%, 10%, and 9%, respectively, of the Company’s total revenue. Additionally, two self-insured customers accounted for approximately 11%, 11%, and 12% of the Company’s total revenue during each of the years 2014, 2013, and 2012, respectively.
	The Company had one customer that had a balance of approximately 23% and 29% of the uncollected premium receivable balance at December 31, 2014 and 2013, respectively.
	The Company maintains its cash in bank deposit accounts, which at times exceed federally insured limits. The Company has not experienced any losses in such accounts.
	Fair Value of Financial Instruments— Certain financial instruments are required to be recorded at fair value. The Company primarily bases fair value for investments in fixed-maturity securities (including federally-insured certificates of deposits, investment grade corporate bonds and non-investment grade corporate bonds) on quoted market prices or on prices from a pricing vendor, an outside resource that supplies securities pricing, dividend, corporate action and descriptive information to support pricing, securities operations, research and portfolio management. The Company obtains and reviews the pricing service’s valuation methodologies and validates these prices using various inputs, including quotes from other independent regulatory sources. When deemed necessary, the Company validates prices by replicating a sample using a discounted cash flow model. Changes in assumptions or estimation methods could affect the fair value estimates.

Note_2_Goodwill_and_Intangible

Note 2 - Goodwill and Intangible Assets	12 Months Ended
	Dec. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets Disclosure [Text Block]	2.     GOODWILL AND INTANGIBLE ASSETS
	Goodwill and intangible assets were recorded as a result of the acquisition of Adenta, Inc. in 2005 related to goodwill, an acquired contract, memberships and a provider network. Goodwill amounted to approximately $136,000 at December 31, 2014 and 2013. There has not been any impairment on goodwill. Identifiable and amortizable intangible assets amounted to approximately $81,000 net of approximately $159,000 of accumulated amortization at December 31, 2014 and to approximately $97,000 net of approximately $143,000 of accumulated amortization at December 31, 2013. Amortization expense was approximately $15,000 for each of the three years ended December 31, 2014, 2013 and 2012. The provider network intangible asset of approximately $57,000 at December 31, 2014 is being amortized over a period of 20 years, a period during which the Company expects that all of these providers will have retired from the network. Membership intangible assets (net of individual memberships written-off in the year of acquisition) of approximately $24,000 at December 31, 2014 are being amortized over an 11 year useful life in accordance with the Company’s expectation for the membership retention. The remaining weighted-average amortization period for these intangible assets is approximately 8 years. Amortization expense for 2015 and 2016 is expected to be approximately $15,000 each year. Goodwill and intangible assets are included in other assets in the accompanying consolidated balance sheets at December 31, 2014 and 2013.

Note_3_Investments

Note 3 - Investments	12 Months Ended
	Dec. 31, 2014
Investments, Debt and Equity Securities [Abstract]
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]	3.      INVESTMENTS
	The Company owned certificates of deposit insured by the Federal Deposit Insurance Corporation (“FDIC”) with an amortized cost of $1,050,000 and $1,200,000 as of December 31, 2014 and 2013, respectively. The certificates of deposit included in short-term and fixed maturities investments are classified as available-for-sale and are carried at fair value. At December 31, 2013, the Company also invested in money market funds included in short-term investments and classified as available-for-sale, with a cost and fair value of approximately $60,000. The Company invested in corporate bonds with an amortized cost of approximately $7,047,000 and $5,936,000 as of December 31, 2014 and 2013, respectively. The investment and non-investment grade corporate bonds included in fixed maturity investments are classified as available-for-sale and are carried at fair value.
	The Company owned 107 corporate bonds at December 31, 2014, which consist primarily of investment grade securities. At December 31, 2014, total bond fair value was approximately $7,196,000, which consists of 67 different securities each with a credit rating of A- or better totaling approximately $5,247,000. The remaining 40 securities, totaling approximately $1,949,000 had a credit rating of between BBB+ and B-. The weighted average yield-to-cost of the Company’s corporate bonds was approximately 3.18% at December 31, 2014. The weighted average maturity of the Company’s corporate bonds was 5.10 years at December 31, 2014. The unrealized gains and losses on available-for-sale investment activity are due to a change in fair value for these investments caused primarily by changes in prevailing interest rates since they were purchased. There were approximately $30,000 realized gains for the year ended December 31, 2014, respectively. There were no material realized gains or losses for the year ended December 31, 2013.
	At December 31, 2014 and, 2013, maturity dates for fixed maturities and short-term investments (excluding the money market funds) were:
		Available-for-Sale
		Amortized		Fair		% of
		Cost		Value		Total Value
	31-Dec-14
	Maturity dates occurring:
	Less than 1 year (Three certificates of deposit)	$	700,000	$	704,676		8.5	%
	Greater than 1 year (Two certificates of deposit and 107 corporate bonds)		7,397,358		7,547,366		91.5	%
	Total	$	8,097,358	$	8,252,042		100	%
		Available-for-Sale
		Amortized		Fair		% of
		Cost		Value		Total Value
	31-Dec-13
	Maturity dates occurring:
	Less than 1 year (Two certificates of deposit)	$	200,000	$	201,027		2.8	%
	Greater than 1 year (Six certificates of deposit and 108 corporate bonds)		6,986,176		7,068,365		97.2	%
	Total	$	7,186,176	$	7,269,392		100	%
	Investments classified at December 31, 2014 and 2013, as fixed maturities and short-term investments were as follows:
		Available-for-Sale
				Gross		Gross
		Amortized		Unrealized		Unrealized			Fair
		Cost		Gain		Loss			Value
	31-Dec-14
	Certificates of deposit, short term	$	700,000	$	4,676				$	704,676
	Certificates of deposit, fixed maturities		350,000		926					350,926
	Corporate bonds, fixed maturities		7,047,358		184,630	$	(35,548	)		7,196,440
	Total investments	$	8,097,358	$	190,232	$	(35,548	)	$	8,252,042
		Available-for-Sale
				Gross		Gross
		Amortized		Unrealized		Unrealized			Fair
		Cost		Gain		Loss			Value
	December 31, 2013
	Money market fund	$	60,217						$	60,217
	Certificates of deposit, short term		200,000	$	1,027					201,027
	Certificates of deposit, fixed maturities		1,050,000		8,693	$	(1,625	)		1,057,068
	Corporate bonds, fixed maturities		5,936,176		128,023		(52,902	)		6,011,297
	Total investments	$	7,246,393	$	137,743	$	(54,527	)	$	7,329,609
	Unrealized losses at December 31, 2014 and 2013 on investments were generally due to higher current market yields relative to the yields of the investments at their amortized cost. Unrealized losses due to credit risk associated with the underlying collateral of the investments, if any, are not material. All investments with unrealized losses are reviewed quarterly to determine if any impairment is other than temporary, requiring a charge to earnings. The Company considers the severity of the loss on a security, duration of loss, duration of the investment, credit rating of the security, as well as payment performance and the Company’s intent or requirement to sell the investment before recovery when determining whether any impairment is other than temporary. The Company had no other than temporary impairment charges for the years ended December 2014, 2013 and 2012. The Company had no investments in a material unrealized loss position for greater than one year as of December 31, 2014 and 2013.

Note_4_Accumulated_Other_Compr

Note 4 - Accumulated Other Comprehensive Income	12 Months Ended
	Dec. 31, 2014
Disclosure Text Block [Abstract]
Comprehensive Income (Loss) Note [Text Block]	4.    ACCUMULATED OTHER COMPREHENSIVE INCOME
	Accumulated other comprehensive income includes changes in unrealized gains and losses on available for sale and other invested assets as follows:
		2014									2013
		Before Tax			Income Tax			Net			Before Tax			Income Tax			Net
	Accumulated unrealized gains, net on investments available for sale, beginning of period	$	85,588		$	29,101		$	56,487		$	251,796		$	85,614		$	166,182
	Other comprehensive income (loss) before reclassification		99,917			33,974			65,943			(166,208	)		(56,513	)		(109,695	)
	Reclassification adjustment for realized investment gains (losses), net included in realized gains on investments, net		(29,691	)		(10,095	)		(19,596	)
	Effect on other comprehensive income (loss)		70,226			23,879			46,347			(166,208	)		(56,513	)		(109,695	)
	Accumulated unrealized gains, net, on investments available for sale, end of period	$	155,814		$	52,980		$	102,834		$	85,588		$	29,101		$	56,487
	Accumulated unrealized gains (losses), net, on interest rate swap, beginning of period	$	(55,618	)	$	(18,911	)	$	(36,707	)	$	(41,275	)	$	(14,034	)	$	(27,241	)
	Other comprehensive income before reclassification		50,764			17,260			33,504			(14,343	)		(4,877	)		(9,466	)
	Reclassification adjustment for realized interest swap loss, net included in realized gains on investments, net		-			-			-			-			-			-
	Effect on other comprehensive income (loss)		50,764			17,260			33,504			(14,343	)		(4,877	)		(9,466	)
	Accumulated unrealized gains, net, on interest rate swap, end of period	$	(4,854	)	$	(1,651	)	$	(3,203	)	$	(55,618	)	$	(18,911	)	$	(36,707	)
	Accumulated other comprehensive income, beginning of period	$	29,970		$	10,190		$	19,780		$	210,521		$	71,580		$	138,941
	Change in unrealized gains (losses), net, on investments available for sale		70,226			23,879			46,347			(166,208	)		(56,513	)		(109,695	)
	Change in unrealized gains (losses), net, on interest rate swap		50,764			17,260			33,504			(14,343	)		(4,877	)		(9,466	)
	Effect on other comprehensive income		120,990			41,139			79,851			(180,551	)		(61,390	)		(119,161	)
	Accumulated other comprehensive income, end of period	$	150,960		$	51,329		$	99,631		$	29,970		$	10,190		$	19,780
		2012
		Before Tax			Income Tax			Net
	Accumulated unrealized gains, net on investments available for sale, beginning of period	$	74,876		$	25,460		$	49,416
	Other comprehensive income (loss) before reclassification		217,225			73,856			143,369
	Reclassification adjustment for realized investment gains (losses), net included in realized gains on investments, net		(40,305	)		(13,702	)		(26,603	)
	Effect on other comprehensive income (loss)		176,920			60,154			116,766
	Accumulated unrealized gains, net, on investments available for sale, end of period	$	251,796		$	85,614		$	166,182
	Accumulated unrealized gains (losses), net, on interest rate swap, beginning of period	$	(16,354	)	$	(5,560	)	$	(10,794	)
	Other comprehensive income before reclassification		(30,821	)		(10,479	)		(20,342	)
	Reclassification adjustment for realized interest swap loss, net included in realized gains on investments, net		5,900			2,005			3,895
	Effect on other comprehensive income (loss)		(24,921	)		(8,474	)		(16,447	)
	Accumulated unrealized gains, net, on interest rate swap, end of period	$	(41,275	)	$	(14,034	)	$	(27,241	)
	Accumulated other comprehensive income, beginning of period	$	58,522		$	19,900		$	38,622
	Change in unrealized gains (losses), net, on investments available for sale		176,920			60,154			116,766
	Change in unrealized gains (losses), net, on interest rate swap		(24,921	)		(8,474	)		(16,447	)
	Effect on other comprehensive income		151,999			51,680			100,319
	Accumulated other comprehensive income, end of period	$	210,521		$	71,580		$	138,941

Note_5_Liability_for_Claims_Pa

Note 5 - Liability for Claims Payable	12 Months Ended
	Dec. 31, 2014
Liability For Claims Payable [Abstract]
Liability For Claims Payable [Text Block]	5	LIABILITY FOR CLAIMS PAYABLE
	Activity in the liability for claims payable for members is summarized as follows:
			2014		2013			2012
	Balance—January 1		$	2,219,725	$	2,136,010		$	2,801,468
	Net incurred claims related to:
	Current year			48,580,639		45,865,228			42,909,476
	Prior years			75,288		(146,287	)		(147,671	)
	Net incurred claims			48,655,927		45,718,941			42,761,805
	Net paid claims related to:
	Current year			45,587,042		43,648,282			40,775,534
	Prior years			2,290,997		1,986,944			2,651,729
	Net paid claims			47,878,039		45,635,226			43,427,263
	Balance—December 31		$	2,997,613	$	2,219,725		$	2,136,010

Note_6_Federal_Income_Taxes

Note 6 - Federal Income Taxes	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	6	FEDERAL INCOME TAXES
	The components of the provision for income taxes are summarized as follows for the years ended December 31, 2014, 2013 and 2012, respectively:
			2014			2013			2012
	Current tax expense:
	Federal		$	1,020,061		$	811,632		$	973,336
	State and local			19,716			13,610			20,128
	Total current tax expense			1,039,777			825,242			993,464
	Deferred tax benefit
	Federal			(144,499	)		(64,374	)		(264,378	)
	State and local			(7,536	)		(6,029	)		(8,649	)
	Total deferred tax benefit			(152,035	)		(70,403	)		(273,027	)
	Total provision for income taxes		$	887,742		$	754,839		$	720,437
	Deferred tax assets and liabilities are comprised of the following:
			2014			2013
	Deferred tax assets:
	Unearned premiums		$	73,616		$	107,785
	Net operating loss			33,404			37,490
	Recapitalization intangible			48,234			48,234
	Accrued vacation			66,998			74,228
	Accrued commissions			218,922			166,610
	Deferred compensation			940,593			701,346
	Accrued professional fees			46,342			43,282
	Other, net			52,042			40,796
	Gross deferred tax assets			1,480,151			1,219,771
	Valuation Allowance			(48,234	)		(48,234	)
	Gross deferred tax assets, net of valuation allowance			1,431,917			1,171,537
	Deferred tax liabilities:
	Unrealized gain on investments			51,326			10,192
	Deferred policy acquisition costs			101,684			111,355
	Prepaid insurance			70,772			66,154
	Property and equipment			122,119			3,503
	Identifiable intangible assets			27,571			32,790
	Gross deferred tax liabilities			373,472			223,994
	Net deferred tax asset		$	1,058,445		$	947,543
	Management believes it is more likely than not that deferred tax assets, net of valuation allowance will reduce future income tax payments. Significant factors considered by management in its determination of the probability of the realization of the deferred tax benefits include the historical operating results and the expectations of future earnings. The Company had $98,247, $110,265, and $122,544 of net operating loss carry forwards to utilize in future years at December 31, 2014, 2013, and 2012, respectively. These losses will expire between 2018 and 2024. Net deferred tax assets are included in other assets in the accompanying consolidated balance sheets at December 31, 2014 and 2013.
	The Company’s effective tax rate was different from the U.S statutory rate due to the following:
												2014			2013			2012
												Effective Tax			Effective Tax			Effective Tax
			2014			2013			2012			Rate			Rate			Rate
	Provision computed at statutory rate		$	757,831		$	692,391		$	693,074			34	%		34	%		34	%
	State and local taxes			4,575			2,954			4,864			0.2			0.1			0.2
	Nondeductible meals, entertainment and legal expense			11,603			9,453			8,815			0.5			0.5			0.4
	Nondeductible federal premium tax			113,733									5.1
	Valuation Allowance						48,243									2.4
	Other—net						1,798			13,684						0.1			0.7
	Provision for income taxes		$	887,742		$	754,839		$	720,437			39.8	%		37.1	%		35.3	%
	On September 13, 2013, the Internal Revenue Service released final tangible property regulations under Sections 162(a) and 263(a) of the Internal Revenue Code of 1986 (“Code”), regarding the deduction and capitalization of expenditures related to tangible property. The final regulations replace temporary regulations that were issued in December 2011. Also released were proposed regulations under Section 168 of the Code regarding dispositions of tangible property. These regulations generally apply to taxable years beginning on or after January 1, 2014 and did not have a material effect to the consolidated financial statements.

Note_7_Accounting_for_Uncertai

Note 7 - Accounting for Uncertain Tax Positions	12 Months Ended
	Dec. 31, 2014
Accounting For Uncertain Tax Positions [Abstract]
Accounting For Uncertain Tax Positions [Text Block]	7	ACCOUNTING FOR UNCERTAIN TAX POSITIONS
	For the years ended December 31, 2014, 2013, and 2012, the Company did not have any significant uncertain tax positions. The Company is primarily subject to U.S. federal and various U.S. state and local tax authorities. Tax years subsequent to 2010 remain open to examination by the Internal Revenue Service (“IRS”), and tax years subsequent to 2009 remain open to other state and local tax authorities.

Note_8_Property_and_Equipment

Note 8 - Property and Equipment	12 Months Ended
	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment Disclosure [Text Block]	8. PROPERTY AND EQUIPMENT
	Property and equipment at December 31 were summarized as follows:
		2014			2013
	Land	$	364,000		$	364,000
	Building and building improvements		2,494,601			2,435,101
	Furniture and equipment		2,787,159			2,402,545
	Total property and equipment		5,645,760			5,201,646
	Less accumulated depreciation	$	(2,968,846	)	$	(2,728,361	)
	Total property and equipment - net	$	2,676,914		$	2,473,285
	The Company had depreciation expense of approximately $318,000, $347,000 and $271,000 for the years ended December 31, 2014, 2013 and 2012, respectively.

Note_9_Deferred_Compensation_P

Note 9 - Deferred Compensation Plan	12 Months Ended
	Dec. 31, 2014
Compensation Related Costs [Abstract]
Compensation Related Costs, General [Text Block]	9	DEFERRED COMPENSATION PLAN
	Share-based compensation cost is measured at the grant date based on the fair value of the awards and is recognized as expense over the vesting periods and is included in total insurance expense in the consolidated statements of comprehensive income. The fair value of the awards is remeasured at the end of each reporting period through the remaining vesting period with the change in fair value recognized in earnings.
	In accordance with the 2006 Dental Care Plus Management Equity Incentive Plan and the Dental Care Plus, Inc. and DCP Holding Company Deferred Compensation Plan (the “Plans”), Company directors and certain key employees elected to defer portions of their director fees and employee compensation, as applicable. The Company recorded expense of approximately $130,000, $67,000, and $88,000 related to deferred director fees and deferred employee compensation for the years ended December 31, 2014, 2013 and 2012, respectively. Directors and key employees who elect to defer cash compensation may request that the Company invest this compensation in a mutual fund investment or phantom shares of the Company. The deferred cash compensation is included in the deferred compensation liability at December 31, 2014 and 2013.
	The Plans also provide for the directors and key employees to receive share awards based on the book value of the Redeemable Common Shares and to elect to defer receiving such amounts until termination of board membership or employment and vesting requirements are met. If a director or key employee does not elect to defer receiving his or her share awards, the individual will receive Class B Redeemable Common Shares upon vesting. If the share awards are deferred, these deferred amounts will be paid in cash at redemption. An individual director’s award vests 100% at the end of each year if the director meets certain attendance requirements. The key employee awards vest 10%, 20%, 30% and 40% at the end of each respective year in a four-year period following the grant date. There are no performance criteria associated with the vesting of the awards for key employees and the only requirement for vesting is that the individual is an employee of the Company at the end of the vesting year in question. There were approximately 145 and 165 of these non-vested awards outstanding at December 31, 2014 and 2013, respectively. The number of awards expected to vest approximates the total non-vested awards outstanding.
	The Company has a long-term incentive compensation program for named executive officers pursuant to which an officer may receive an award of up to 45% of such officer’s base salary in the form of share awards which will vest if established Company performance criteria are achieved over a three year period. There were approximately 337 and 480 of these non-vested awards outstanding at December 31, 2014 and 2013, respectively.
	The deferred compensation expense related to these awards is recorded ratably during the applicable vesting period. The Company recorded deferred compensation expense of approximately $872,000, $616,000, and $466,000, with a tax benefit of approximately $296,000, $209,000, and $158,000, related to deferred share awards and the change in the value of phantom shares for the years ended December 31, 2014, 2013 and 2012, respectively. As of December 31, 2014, there is approximately $301,000 of total unrecognized compensation cost related to non-vested awards under the Plans. That cost is expected to be recognized over a weighted average period of 1.34 years.
	In February 2014 and 2013, the Board declared a per share cash dividend for all Class A, Class B and Class C redeemable common shares in the amounts of $35.77 and $32.60 per share, respectively. With the dividend, the holders of restricted share units and phantom shares received an equivalent share based dividend that resulted in an increase in the deferred compensation liability of approximately $41,000 and $52,000 in February 2014 and February 2013, respectively.
	The maximum aggregate number of share based awards that may be issued under the Plans are 15,000 Class B Common Shares. In 2014, the non-employee members of the Board were granted a total of 252 share based awards. In 2014, key employees were granted 295 share based awards. As of December 31, 2014, the Company has granted a total of 3,293 share awards, net of share based dividends, forfeitures and rescinded share awards.
	The following is a summary of activity of non-vested awards for the years ended December 31, 2014 and 2013:
			Individual Director's Share Awards			Weighted Average Grant Date Fair Value		Key Employee Share Awards			Fair Value at
											December 31,2014
	Non-vested awards at January 1, 2014								644.6
	Granted			252		$	894		295
	Vested			(252.0	)		894		(433.1	)
	Forfeited								(24.6	)
	Non-vested awards at December 31, 2014								481.9		$	1,018
			Individual Director's Share Awards			Weighted Average Grant Date Fair Value		Key Employee Share Awards			Fair Value at
											December 31,2013
	Non-vested awards at January 1, 2013								535.8
	Granted			252		$	886		204
	Vested during the year			(252.0	)		886		(74.2	)
	Forfeited								(21.0	)
	Non-vested awards at December 31, 2013								644.6		$	920
	The following is a summary of activity of vested awards for the years ended December 31, 2014 and 2013:
			Individual Director's Awards			Weighted Average Vested price		Key Employee Awards			Fair Value at
											December 31,2014
	Vested awards at January 1, 2014			806.7		$	886		408.5
	Share based dividend			32.5			887		13.4
	Vested during the year			252			1,015		433.1
	Redeemed vested awards								(76.2	)
	Converted to Redeemable Common Shares			(252.0	)		1,015
	Vested awards at December 31, 2014			839.2			1,018		778.8		$	1,018
			Individual Director's Awards			Weighted Average Vested price		Key Employee Awards			Fair Value at December 31,2013
	Vested awards at January 1, 2013			876		$	815		339.7
	Share based dividend			34.5			828		13.4
	Vested during the year			252			881		74.2
	Redeemed vested awards			(103.8	)		794		(14.8	)
	Converted to Redeemable Common Shares			(252.0	)		881		(4.0	)
	Vested awards at December 31, 2013			806.7			886		408.5		$	920

Note_10_Redeemable_Shares_Shar

Note 10 - Redeemable Shares, Shareholders' Equity and Dividend Restrictions	12 Months Ended
	Dec. 31, 2014
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	10. REDEEMABLE SHARES, SHAREHOLDERS’ EQUITY AND DIVIDEND RESTRICTIONS
	Participating providers along with Company directors and employees have the option to purchase one or more voting Class B Redeemable Common Shares of the Company, when offered. Non-dentist individuals are eligible to purchase Class C voting redeemable common shares, when offered. The maximum percentage of Class C Common Shares outstanding at any time as a proportion of all voting Common Shares is 40%. The book value of a common share was approximately $997 and $894 at December 31, 2014 and 2013, respectively. In 2014, 2013 and 2012, the Board declared a per share cash dividend for all Class A, Class B and Class C redeemable common shares in the amounts of $35.77, $32.60 and $21.00, respectively.
	The Company has 100,000 authorized Class D Redeemable Common Shares, without par value. The Class D Redeemable Common Shares are non-voting redeemable common shares that Preferred Shares may be converted to under certain circumstances. As of December 31, 2014 and 2013, none of these Class D redeemable shares were issued or are outstanding.
	The Company is authorized to issue 100,000 preferred shares, without par. In 2010, the Company entered into a Preferred Stock Purchase Agreement with an investor for 300 Redeemable Institutional Preferred Shares at a purchase price of $1,000 per share. In 2012 and 2013, the Company entered into additional Stock Purchase Agreements with an investor for the sale of 1,000 Redeemable Institutional Preferred Shares each year at a purchase price of $1,000 per share. The annual dividend payable on each Redeemable Institutional Preferred Share is 5% of the book value at the beginning of the dividend period. As of December 31, 2014, 2013, and 2012, dividends declared were approximately $128,000, $123,000, and $67,000, respectively. As of December 31, 2014, 2013, and 2012, dividends paid were approximately $128,000, $123,000, and $83,000, respectively.
	Redeemable Provider Preferred Shares-2009 Series are entitled to a cumulative cash dividend equal to 5% of the year end book value of the Redeemable Provider Preferred Shares. As of December 31, 2014 and 2013, none of these Provider Preferred Shares were issued or are outstanding.
	Dividend restrictions vary among the subsidiaries. Dental Care Plus is restricted by regulatory requirements of its domiciliary state, which limit by reference to statutory net income and net worth, the dividends that can be paid without prior regulatory approval. Dividends paid by Dental Care Plus cannot, without prior approval of the Ohio Department of Insurance, exceed in any one year the lesser of: (i) 10% of net worth (as of the preceding December 31), or (ii) net income for the prior year, and only if net worth exceeds $250,000 and only out of unassigned surplus. There were no dividends declared or paid by any subsidiaries during 2014 or 2013. In December 2012, Dental Care Plus declared and paid a dividend to the Company totaling $360,000. During 2015, the total dividend that the Dental Care Plus subsidiary may declare without prior regulatory approval is approximately $969,000.
	GAAP differs in certain respects from the accounting practices prescribed or permitted by state insurance regulatory authorities (“statutory-basis”), a non-GAAP basis of accounting. The statutory-basis net income for Dental Care Plus was approximately $1,156,000, $1,191,000, and $1,108,000 for the years ended December 31, 2014, 2013 and 2012, respectively. Statutory-basis equity was approximately $9,689,000 and $8,560,000 at December 31, 2014 and 2013, respectively.

Note_11_Debt

Note 11 - Debt	12 Months Ended
	Dec. 31, 2014
Debt Disclosure [Abstract]
Debt Disclosure [Text Block]	11.DEBT
	In December 2012, the Company refinanced the mortgage of its office building and in connection therewith, the Company executed a mortgage note with a bank, secured by the land and the office building, in the amount of $1,340,000. Interest is payable based on the 30-day LIBOR rate plus 1.95%. As a result of the mortgage note having a variable interest rate that adjusts monthly with the 30-day LIBOR rate, the carrying value of the mortgage note of $1,247,600 approximates fair value. The Company also entered into an interest rate swap agreement that effectively changed the interest rate related to the $1,340,000 mortgage note with a commercial bank from a variable rate based on the 30-day LIBOR rate plus 1.95% to a fixed rate of 3.90% for the 10-year period through December 22, 2022. Under this mortgage, the Company is required to have a minimum tangible net worth equal to or greater than $3,500,000 at the end of each fiscal year and a debt service ratio of at least 1:1. The mortgage note fair value disclosure is classified as Level 2 in the fair-value hierarchy.
	Required principal repayments under the mortgage loan payable are as follows:
	Years Ending
	31-Dec
	2015	$	49,200
	2016		50,400
	2017		52,800
	2018		55,200
	2019 and thereafter		1,040,000
	Total mortgage payable	$	1,247,600
	In 2014, the Company entered into a sale-leaseback transaction with a leasing company for the sale of certain fixed assets for approximately $516,000. There was no gain or loss on the sale. The Company did not retain the benefits and risk to the property sold and the risk of ownership was transferred to the leasing company. The Company also entered into a capital lease agreement with the leasing company that obligates the Company to pay lease payments totaling approximately $552,000 related to these assets over a four year period. Under this capital lease agreement, the Company is required to have a minimum tangible net worth equal to or greater than $2,500,000 at the end of each fiscal year.
	In 2013, the Company entered into a sale-leaseback transaction with a leasing company for the sale of certain fixed assets for approximately $312,000. There was no gain or loss on the sale. The Company did not retain the benefits and risk to the property sold and the risk of ownership was transferred to the leasing company. The Company also entered into a capital lease agreement with the leasing company that obligates the Company to pay lease payments totaling approximately $327,000 related to these assets over a three year period. Under this capital lease agreement, the Company is required to have a minimum tangible net worth equal to or greater than $2,500,000 at the end of each fiscal year.
	At December 31, 2014, future required payments under all outstanding capital leases are as follows:
	2015	$	268,595
	2016		249,638
	2017		146,979
	2018		137,929
	2019		11,462
	Total		814,603
	Less imputed interest		(43,125	)
	Present value of minimum lease payments	$	771,478

Note_12_Derivative

Note 12 - Derivative	12 Months Ended
	Dec. 31, 2014
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments and Hedging Activities Disclosure [Text Block]	12. DERIVATIVE
	In December 2012, the Company entered into an interest rate swap agreement (“Agreement”) (cash flow hedge) with an original notional amount of $1,340,000. The Agreement is used to manage the Company’s interest rate risk. The swap agreement effectively changed the interest rate related to the Company’s 2012 refinanced mortgage note with a commercial bank from a variable rate based on the 30-day LIBOR rate plus 1.95% to a fixed rate of 3.90% for the 10-year period through December 22, 2022. The Company’s risk management policy is to not enter into derivatives for speculative purposes. The notional amount decreases in direct correlation to the principal reduction of the mortgage. The Company believes that the risk of nonperformance by the counter party to this Agreement is not material to the financial statements. At December 31, 2014 and 2013, the fair value of this Agreement was a liability of approximately $5,000 and $56,000, respectively. This amount is included in other payables and accruals in the accompanying consolidated balance sheets. The agreement will terminate upon maturity of the mortgage loan payable (Note 11).
	In 2003, the Company previously entered into an interest rate swap agreement (“2003-Agreement”) (cash flow hedge) with an original notional amount of $1,500,000. The swap agreement effectively changed the interest rate related to $1,500,000 of the Company’s $1,800,000 previous mortgage note with a commercial bank from a variable rate based on the 30-day LIBOR rate plus 1.75% to a fixed rate of approximately 4.95%. The 2003-Agreement terminated in December 2012 when the Company refinanced the mortgage note (Note 11). Upon termination of the 2003-Agreement, the Company realized a loss of approximately $5,900, which is included in realizable gains (losses) on investments, net in the accompanying consolidated statements of comprehensive income for the year ended December 31, 2012.
	The amounts included in other comprehensive income (loss) related to the interest rate swaps were $33,504, $(9,466), and ($16,447), net of income tax expense (benefit) of $17,260, $(4,877), and $(8,474), during 2014, 2013 and 2012, respectively.

Note_13_Lines_of_Credit

Note 13 - Lines of Credit	12 Months Ended
	Dec. 31, 2014
Lines Of Credit [Abstract]
Lines Of Credit [Text Block]	13	LINES OF CREDIT
	The Company has an annually renewable agreement with a commercial bank for a $500,000 working capital line of credit. Interest is payable at a variable rate of LIBOR plus 2.50%. The Company did not have any interest expense or significant fees for the line of credit for each of the three years ended December 31, 2014. As of December 31, 2014 and 2013, there was no amount outstanding on this line of credit. The $500,000 working capital line of credit expires in July 2015.
	The Company has an additional annually renewable working capital line of credit for $1,000,000. Interest is payable at a variable rate of LIBOR plus 2.50%. The Company did not have any interest expense or significant fees for the line of credit for each of the three years ended December 31, 2014. At December 31, 2014 and 2013, there was no amount outstanding on this line of credit. The $1,000,000 working capital line of credit expires in July 2015. In addition, the Company had an irrevocable letter of credit for $10,000, with interest payable on all outstanding amounts at a variable rate of the prime rate of borrowing plus 6.00%. The letter of credit also had an annual fixed rate of 2.10% for access to the letter of credit obligation. The letter of credit expired in December 2014 and was not renewed.

Note_14_Commitments_and_Contin

Note 14 - Commitments and Contingencies	12 Months Ended
	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	14	COMMITMENTS AND CONTINGENCIES
	Leases—The Company leases certain equipment and office space under non-cancelable operating leases. Rent expense under all operating leases was approximately $154,000, $136,000, and $118,000 for the years ended December 31, 2014, 2013 and 2012, respectively.
	At December 31, 2014, future approximate minimum annual lease payments under non-cancelable operating leases are as follows:
	Years Ending
	31-Dec
	2015		$	156,000
	2016			126,000
	2017			46,000
	2018			36,000
	2019 and thereafter			17,000
	Total		$	381,000
	Litigation—In the normal course of business, the Company is subject to various regulatory proceedings, lawsuits, claims and other matters. We are not aware of any matters which are more than remote in possibility and in the opinion of the Company’s management, the eventual resolution of such matters for amounts above those reflected in the consolidated financial statements would not have a material adverse effect on the financial condition or results of operations of the Company.

Note_15_Lease_Income

Note 15 - Lease Income	12 Months Ended
	Dec. 31, 2014
Lease Income [Abstract]
Lease Income [Text Block]	15.      LEASE INCOME
	The Company leases space in its building to unrelated parties under non-cancelable leases. Income recorded by the Company under non-cancelable leases amounted to approximately $62,000, $62,000, and $68,000 for the years ended December 31, 2014, 2013 and 2012. Such amounts are recorded as other income in the accompanying consolidated statements of comprehensive income. As of December 31, 2014, the Company has approximately $62,000 of future minimum annual lease income under non-cancelable leases in 2015.

Note_16_Retirement_Plan

Note 16 - Retirement Plan	12 Months Ended
	Dec. 31, 2014
Disclosure Text Block Supplement [Abstract]
Compensation and Employee Benefit Plans [Text Block]	16	RETIREMENT PLAN
	Employees of the Company are covered by a defined contribution 401(k) plan sponsored by the Company. Discretionary contributions of a certain percentage of each employee’s contribution, which may not exceed a limit set annually by the Internal Revenue Service, are contributed by the Company each year and vest ratably over a five-year period. Company contributions, including administration fees paid by the Company, amounted to approximately $60,000 for the years ended December 31, 2014, 2013 and 2012.

Note_17_Segment_Information

Note 17 - Segment Information	12 Months Ended
	Dec. 31, 2014
Segment Reporting [Abstract]
Segment Reporting Disclosure [Text Block]	17	SEGMENT INFORMATION
	The Company manages its business with four segments: fully-insured dental HMO and indemnity, fully-insured dental PPO, self-insured dental and corporate, all other. Self-insured dental consists of the self-insured dental HMO, self-insured dental PPO and self-insured dental indemnity products. Corporate, all other consists of revenue associated with the Company’s dental indemnity, dental PPO, and vision products underwritten by third-party insurance carriers and certain other corporate activities. These segments are consistent with information used by the Chief Executive Officer (the chief operating decision maker) in managing the business.
	The results of the fully-insured dental HMO and indemnity, fully-insured dental PPO and self-insured dental segments are measured by gross profit. The Company does not allocate insurance expense, investment and other income, assets or liabilities to these segments because the Company does not use these measures to analyze the segments. These items are assigned to the remainder of the Company’s business, which it identifies as corporate, all other. The Company’s gross profit was approximately $20,240,000, $18,601,000, and $16,417,000, for the years ended December 31, 2014, 2013 and 2012, respectively.
	Listed below is financial information required for each reportable segment for the years ended December 31, 2014, 2013 and 2012 (amounts in thousands):
			Fiscal Year Ended						Fiscal Year Ended
			31-Dec-14						31-Dec-13
			Revenues-		Healthcare				Revenues-		Healthcare
			External		Services				External		Services
			Customers		Expense		Total		Customers		Expense		Total
	Reportable segments:
	Fully-insured dental HMO/Indemnity		$	47,948	$	35,995	$	11,953	$	46,656	$	35,024	$	11,632
	Fully-insured dental PPO			16,459		12,661		3,798		13,494		10,695		2,799
	Self-insured dental			26,905		23,040		3,865		25,641		22,043		3,598
	Corporate, all other			624				624		572				572
	Total		$	91,936	$	71,696		20,240	$	86,363	$	67,762		18,601
	Investment income							222						164
	Realized gains on investments, net							30
	Other income							62						61
	Insurance expense							18,325						16,790
	Income before income tax						$	2,229					$	2,036
	Total assets-corporate						$	57,239					$	56,903
			Fiscal Year Ended
			31-Dec-12
			Revenues-		Healthcare
			External		Services
			Customers		Expense		Total
	Reportable segments:
	Fully-insured dental HMO/Indemnity		$	43,844	$	33,399	$	10,445
	Fully-insured dental PPO			11,429		9,363		2,066
	Self-insured dental			24,380		20,974		3,406
	Corporate, all other			500				500
	Total		$	80,153	$	63,736		16,417
	Investment income							128
	Realized gains on investments, net							34
	Other income							68
	Insurance expense							14,609
	Income before income tax						$	2,038
	Total assets-corporate						$	37,337
	Inter-segment revenues were not significant for 2014, 2013, or 2012.

Note_18_Related_Parties

Note 18 - Related Parties	12 Months Ended
	Dec. 31, 2014
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	18	RELATED PARTIES
	All of the Company’s Class A, and Class B shareholders are related parties, either as a participating provider, director or an employee of the Company.
	The Company’s providers, who are also shareholders, submitted claims of approximately $36,902,000, $37,566,000, and $37,720,000 in 2014, 2013 and 2012, respectively. The Company had claims payable liability to related party providers of approximately $1,547,000 and $1,231,000 at December 31, 2014 and 2013, respectively.
	Seven of our Board members are also participating providers and as a group received approximately $191,000, $154,000 and $159,000 in directors’ fees for the years ended December 31, 2014, 2013, and 2012, respectively.

Note_19_Fair_Value_Measurement

Note 19 - Fair Value Measurements	12 Months Ended
	Dec. 31, 2014
Fair Value Disclosures [Abstract]
Fair Value Disclosures [Text Block]	19	FAIR VALUE MEASUREMENTS
	The Company classifies the assets and liabilities that require measurement of fair value based on the priority of the observable and market-based sources of data into a three-level fair value hierarchy. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are as follows:
		●	Level 1 – Valuations based on quoted prices in active markets for identical assets or liabilities that the entity has the ability to access.
		●	Level 2 – Valuations based on significant other observable inputs other than those included in Level 1 such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities.
		●	Level 3 – Valuations based on unobservable inputs such as when observable inputs are not available or inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
	The following table presents for each of the fair value levels, the Company’s assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2014 and 2013 (amounts in thousands):
			31-Dec-14						31-Dec-13
			Level 1		Level 2		Total Balance		Level 1		Level 2		Total Balance
	Assets
	Fixed maturities
	Federally-Insured certificates of deposit				$	351	$	351			$	1,057	$	1,057
	Investment grade corporate bonds					6,780		6,780				6,011		6,011
	Non-investment grade corporate bonds					416		416
	Short-term investments
	Money Short-term investmentsmarket fund								$	60				60
	Federally-Insured certificates of deposit					705		705				201		201
	Deferred compensation investments (a)
	Equity mutual fund investments		$	530				530		419				419
	State guarantee fund deposits (b)
	Government securities			229				229		230				230
	Federally-Insured certificates of deposit					50		50				50		50
	Total		$	759	$	8,302	$	9,061	$	709	$	7,319	$	8,028
	Liabilities
	Interest rate swap (c)				$	5	$	5			$	56	$	56
	Total		$		$	5	$	5	$		$	56	$	56
	(a) Included as a trading security in other assets
	(b) Included in other assets
	(c) Included in other payables and accruals
	The Company measures fair value using the following valuation methodologies. The Company uses quoted market prices to determine the fair value of the deferred compensation investments and certain state fund guarantee deposits; such items are classified as Level 1 of the fair value hierarchy. Examples include government securities and mutual fund equity securities. The Company primarily bases fair value for investments in fixed-maturity securities on quoted market prices or on prices from a pricing vendor, an outside resource that supplies independent securities pricing, dividend, corporate action and descriptive information to support fund pricing, securities operations, research and portfolio management. The Company obtains and reviews the pricing service’s valuation methodologies and validates these prices using various inputs including quotes from other independent regulatory sources. When deemed necessary, the Company validates prices by replicating a sample using a discounted cash flow model. Such items are classified as Level 2 of the fair value hierarchy. The Company obtains a price from an independent vendor to determine the fair value of the interest rate swap. The independent vendor uses a discounted cash flow method whereby the significant observable inputs include the replacement interest rates of similar swap instruments in the market and swap curves; such items are classified as Level 2 of the fair value hierarchy.
	At December 31, 2014 and 2013, there were no assets or liabilities that were required to be measured at fair value on a non-recurring basis. The Company did not have any transfers between fair value hierarchy levels during December 2014 and 2013. As of December 31, 2014 and 2013, the Company did not have any assets or liabilities classified as Level 3 of the fair value hierarchy.

Note_20_Quarterly_Data_Unaudit

Note 20 - Quarterly Data (Unaudited)	12 Months Ended
	Dec. 31, 2014
Quarterly Financial Information Disclosure [Abstract]
Quarterly Financial Information [Text Block]	20	QUARTERLY DATA (UNAUDITED)
	A summary of our unaudited quarterly results of operations for the years ended December 31, 2014 and 2013 is as follows (amounts in thousands):
			2014
			31-Mar		30-Jun		30-Sep		31-Dec		Total
	Premium revenue		$	22,636	$	22,851	$	23,578	$	22,871	$	91,936
	Gross profit			4,559		4,883		4,937		5,861		20,240
	Income before income taxes			195		363		882		789		2,229
			2013
			31-Mar		30-Jun		30-Sep		31-Dec		Total
	Premium revenue		$	20,849	$	21,415	$	22,614	$	21,485	$	86,363
	Gross profit			3,895		4,673		4,376		5,657		18,601
	Income before income taxes			140		581		188		1,127		2,036

Note_21_Subsequent_Events

Note 21 - Subsequent Events	12 Months Ended
	Dec. 31, 2014
Subsequent Events [Abstract]
Subsequent Events [Text Block]	21.  SUBSEQUENT EVENTS
	In accordance with the provisions of the Affordable Care Act of 2010, the federal government imposed an annual assessment on all U.S. health insurers of approximately $11.3 billion in 2015. This annual assessment will increase each year and is expected to be $16.0 billion in 2019. This annual assessment is allocated to individual health insurers based on the ratio of the insurer’s net premiums written during the preceding calendar year to the total health insurance premiums for any U.S. risk premium written for that same year. The first $25 million of a health insurer’s net premium written is exempt from the federal premium tax assessment. The net premium written by a health insurer from $25 million to $50 million is subject to 50% of the federal premium tax rate. Accordingly, in January 2015, the Company established a liability for the federal premium tax of approximately $530,000 that is payable to the United States Treasury in September 2015, along with an offsetting asset that will be amortized during 2015.
	On February 11, 2015, the Company’s Board of Directors declared a $39.86 per share dividend for all Class A, Class B and Class C redeemable common shareholders of record on February 11, 2015, payable on March 27, 2015. With the dividend, the holders of restricted share units will receive an equivalent share based dividend.

Schedule_I_Summary_of_Investme

Schedule I - Summary of Investments - Other Than Investments in Relate Parties	12 Months Ended
	Dec. 31, 2014
Summary of Investments, Other than Investments in Related Parties [Abstract]
Summary of Investments, Other than Investments in Related Parties [Text Block]	Type of Investment	Amortized Cost		Fair Value		Balance Sheet
	Fixed Maturities:
	Bonds:
	All other corporate bonds	$	7,047	$	7,196	$	7,196
	Certificates of deposit		1,050		1,056		1,056
	Total Investments	$	8,097	$	8,252	$	8,252

Schedule_II_Condensed_Financia

Schedule II - Condensed Financial Information of Registrant	12 Months Ended
	Dec. 31, 2014
Condensed Financial Information of Parent Company Only Disclosure [Abstract]
Condensed Financial Information of Parent Company Only Disclosure [Text Block]			2014			2013
	ASSETS
	INVESTMENTS:
	Fixed maturities		$	926,182		$	877,671
	Short-term investments						41,738
	Total investments			926,182			919,409
	CASH AND CASH EQUIVALENTS			1,831,520			1,375,743
	ACCRUED INVESTMENT INCOME			11,165			4,349
	INTERCOMPANY RECEIVABLES			572,005			373,829
	INTERCOMPANY NOTE RECEIVABLE			230,000			230,000
	PROPERTY			1,854,933			1,907,474
	INVESTMENT IN SUBSIDIARIES			10,269,275			9,333,447
	DEFERRED INCOME TAX			1,045,723			811,976
	OTHER ASSETS			789,431			690,855
	TOTAL ASSETS		$	17,530,234		$	15,647,082
	LIABILITIES, REEDEMABLE SHARES, AND SHAREHOLDERS’ EQUITY
	OTHER PAYABLES AND ACCRUALS		$	2,142,091		$	2,183,562
	MORTGAGE LOAN PAYABLE			1,247,600			1,294,400
	DEFERRED COMPENSATION			2,766,449			2,062,783
	TOTAL LIABILITIES			6,156,140			5,540,745
	COMMITMENTS AND CONTINGENCIES
	REDEEMABLE SHARES:
	Institutional Preferred Shares-2010 Series, no par value, cumulative 5% dividend—authorized, 300 shares; issued and outstanding, 300 shares at December 31, 2014 and 2013, respectively			414,173			391,814
	Institutional Preferred Shares-2012 Series, no par value, cumulative 5% dividend—authorized, 1,000 shares; issued and outstanding, 1,000 shares at December 31, 2014 and 2013, respectively			1,195,484			1,130,946
	Institutional Preferred Shares-2013 Series, no par value, cumulative 5% dividend—authorized, 1,000 shares; issued and outstanding, 1,000 shares at December 31, 2014 and 2013, respectively			1,099,604			1,040,242
	Class A, Redeemable Common Shares, no par value—authorized, 7,500 shares; issued and outstanding, 531 and 546 shares at December 31, 2014 and 2013, respectively			529,158			488,282
	Class B Redeemable Common Shares, no par value—authorized, 120,000 shares; issued and outstanding, 7,843 and 7,889 shares at December 31, 2014 and 20132, respectively			7,815,789			7,055,053
	Class C Redeemable Common Shares, no par value—authorized, 80,000 shares; issued and outstanding, 321 and zero shares at December 31, 2014 and 2013, respectively			319,886
	Class D Redeemable Common Shares, no par value—authorized, 100,000 shares;
	Provider Preferred-2009 Series Redeemable Preferred Shares, no par value, cumulative 5% dividend—authorized, 5,000 shares; issued none
	Total redeemable preferred and common shares			11,374,094			10,106,337
	SHAREHOLDERS’ EQUITY—Preferred Shares; no par value—authorized, 92,700 shares; issued, none
	TOTAL LIABILITIES, REDEEMABLE SHARES AND SHAREHOLDERS' EQUITY		$	17,530,234		$	15,647,082
			2014			2013			2012
	REVENUES
	Management fees from subsidiaries		$	11,486,781		$	11,029,944		$	9,531,143
	Investment income			33,528			16,536			7,502
	Administrative fees			798,900			713,915			273,251
	Total revenues			12,319,209			11,760,395			9,811,896
	EXPENSES
	Insurance expense:
	Salaries and benefit expense			7,356,679			6,626,586			5,603,918
	Other insurance expense			4,470,223			5,043,160			3,956,496
	Total expenses			11,826,902			11,669,746			9,560,414
	INCOME BEFORE INCOME TAX			492,307			90,649			251,482
	PROVISION (BENEFIT) FOR INCOME TAX:
	Current			428,152			226,519			284,933
	Deferred			(246,426	)		(134,903	)		(187,044	)
	Total			181,726			91,616			97,889
	Income (Loss) before undistributed income of subsidiaries			310,581			(967	)		153,593
	Undistributed income of subsidiaries			1,030,592			1,282,573			1,164,424
	NET INCOME		$	1,341,173		$	1,281,606		$	1,318,017
	OTHER COMPREHENSIVE INCOME (LOSS), NET OF TAX
	Change in the fair value of interest rate swap									6,900
	Change in the fair value of investments			74,832			(104,983	)		143,369
	Reclassification adjustment for gains included in undistributed income			(19,596	)					(22,708	)
	Total other comprehensive income held by subsidaries			55,236			(104,983	)		127,561
	Change in the fair value of investments			(8,889	)		(4,712	)
	Change in the fair value of interest rate swap			33,504			(9,466	)		(27,242	)
	TOTAL COMPREHENSIVE INCOME		$	1,421,024		$	1,162,445		$	1,418,336
	This condensed financial information should be read in conjunction with the Consolidated Financial Statements and Notes included in Part II, Item 8, Page 34 and the notes to the Condensed Financial Statements.
			2014			2013			2012
	CASH FLOWS FROM OPERATING ACTIVITIES:
	Net income		$	1,341,173		$	1,281,606		$	1,318,017
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization			116,194			110,567
Loss on disposal of property						56,495
Undistributed income of subsidiaries			(1,030,592	)		(1,282,573	)		(1,164,424	)
Deferred income (benefit) tax			(246,426	)		(134,903	)		(187,044	)
Deferred compensation			959,380			675,195			542,630
Effects of changes in operating assets and liabilities:
Accrued investment income			(6,816	)		(4,349	)
Intercompany accounts receivables			(198,176	)		34,003			(403,074	)
Other assets			(89,141	)		(151,936	)		5,839
Other payables and accruals			56,994			339,117			684,596
Net cash provided by operating activities			902,590			923,222			796,540
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of investments			(822,222	)		(885,902	)
Sale and maturities of investments			794,972
Acquisition of property and equipment			(61,250	)		(187,427	)
Acquisition of property from subsidiary									(1,886,004	)
Investment, other			(5,000	)		(5,000	)		(40,000	)
Net cash used in investing activities			(93,500	)		(1,078,329	)		(1,926,004	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Mortgage loan repayments			(46,800	)		(45,600	)
Borrowing of mortgage note									1,340,000
Advance to subsidiaries									(605,478	)
Dividends from subsidiaries to finance real estate			150,000						360,000
Repurchase of redeemable shares			(361,721	)		(264,031	)		(137,891	)
Issuance of redeemable shares			330,535			1,096,959			1,044,245
Additional contribution with share exchange
Dividends paid			(425,327	)		(392,196	)		(260,426	)
Net cash (used in) provided by financing activities			(353,313	)		395,132			1,740,450
INCREASE IN CASH			455,777			240,025			610,986
CASH AND CASH EQUIVALENTS—Beginning of year			1,375,743			1,135,718			524,732
CASH AND CASH EQUIVALENTS—End of year		$	1,831,520		$	1,375,743		$	1,135,718
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for interest		$	47,000		$	52,000
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Redeemed common shares (in other payables and accruals)		$	82,518		$	130,219		$	160,024
Redeemed common shares issued in lieu of cash payment of deferred compensation			255,714			225,522			125,902
Deferred restricted shares units issued in lieu of cash dividend			40,712			52,042			28,210
Class A redeemable common shares exchanged for Class B redeemable common shares						5,672			9,819
1	BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES
Parent company financial information has been derived from our consolidated financial statements and excludes the accounts of all operating subsidiaries. This information should be read in conjunction with our consolidated financial statements.
Parent company maintains its investment in all subsidiaries on the equity method. The investment in subsidiary is adjusted for the changes in other comprehensive income from the subsidiaries.
2	TRANSACTIONS WITH SUBSIDIARIES
Transfer of real estate
In December 2012, the Dental Care Plus, Inc. (“DCP”) subsidiary transferred real estate to the parent totaling approximately $1,886,000.
Management Fee
Through intercompany service agreements approved, if required, by state regulatory agencies, our parent company charges a management fee for reimbursement of certain centralized services provided to its subsidiaries including information systems, investment and cash administration, marketing, legal, finance, executive management oversight and other operating expenses.
Salaries and benefit expense
Salary and benefit expense includes dental benefit expense of approximately $107,000, $92,000, and $80,000, for the years ended December 31, 2014, 2013 and 2012, respectively. These amounts eliminate in consolidation.
Investments in subsidiaries and dividends
In 2014, the parent company received a dividend from the Adenta, Inc. subsidiary in the amount of $150,000. There were no dividends declared or paid to the parent company in 2013.
Federal Income Tax Arrangement
The parent company has an income tax allocation arrangement with its subsidiaries. DCP makes federal tax payments on behalf of the Company. DCP paid approximately $1,270,000, $540,000, and $1,110,000 for the years ended December 31, 2014, 2013, and 2012. The Company’s policy is to settle this intercompany receivable within 30 days of the filing of its consolidated income tax return.
There were no additional investment in subsidiaries in 2014 and 2013.
Reconciliation of Investment in Subsidiaries
		2014			2013
Investment in Subsidiaries—January 1		$	9,333,447		$	8,155,857
Undistributed income of subsidiaries			1,030,592			1,282,573
Total other comprehensive income held by subsidiaries			55,236			(104,983	)
Dividends from subsidiaries to finance real estate			(150,000	)
Increase in Investment in Subsidiary			935,828			1,177,590
Investment in Subsidiaries—December 31		$	10,269,275		$	9,333,447

Schedule_III_Supplementary_Ins

Schedule III - Supplementary Insurance Information	12 Months Ended
	Dec. 31, 2014
Supplementary Insurance Information [Abstract]
Supplementary Insurance Information, for Insurance Companies Disclosure [Text Block]		2014		2013		2012
	Deferred policy acquisition cost (a)	$	2,050	$	2,190	$	1,184
	Claims payable (a)	$	2,998	$	2,220	$	2,136
	Unearned premium (a)	$	32,637	$	35,395	$	19,792
	Other policy claims and benefits payable (a)	$	3,229	$	3,088	$	2,105
	Premium revenues
	Fully-insured dental HMO/ Indemnity	$	47,948	$	46,656	$	43,844
	Fully-insured dental PPO		16,459		13,494		11,429
	Self-insured dental		26,905		25,641		24,380
	Corporate, All Other		624		572		500
		$	91,936	$	86,363	$	80,153
	Investment income (a)	$	222	$	164	$	128
	Future policy benefits, losses, claims and expense losses
	Fully-insured dental HMO/ Indemnity	$	35,995	$	35,024	$	33,399
	Fully-insured dental PPO		12,661		10,695		9,363
	Self-insured dental		23,040		22,043		20,974
		$	71,696	$	67,762	$	63,736
	Amortization of deferred policy acquisition cost (a)	$	4,129	$	3,862	$	3,592
	Other operating expense (a)	$	14,196	$	12,928	$	11,018
	Premium written
	Fully-insured dental (a)	$	62,151	$	75,363	$	52,650
	(a) The Company does not allocate insurance expense, investment and other income, or other assets or liabilities to identified segments.

Schedule_IV_Reinsurance

Schedule IV - Reinsurance	12 Months Ended
	Dec. 31, 2014
Supplemental Schedule of Reinsurance Premiums for Insurance Companies [Abstract]
Supplemental Schedule of Reinsurance Premiums for Insurance Companies [Text Block]		2014		2013		2012
	Gross earned premium amounts
	Fully-insured dental HMO/Indemnity	$	47,948	$	46,656	$	43,844
	Fully-insured dental PPO		16,459		13,456		11,240
	Self-insured dental		26,905		25,641		24,380
	Corporate, All Other		624		572		500
		$	91,936	$	86,325	$	79,964
	Ceded earned premium amounts to other companies
	Fully-insured dental HMO/Indemnity
	Fully-insured dental PPO
	Self-insured dental
	Corporate, All Other
		$		$		$
	Assumed amounts from other companies
	Fully-insured dental HMO/Indemnity
	Fully-insured dental PPO			$	38	$	189
	Self-insured dental
	Corporate, All Other
		$		$	38	$	189
	Net earned premium amounts
	Fully-insured dental HMO/Indemnity	$	47,948	$	46,656	$	43,844
	Fully-insured dental PPO		16,459		13,494		11,429
	Self-insured dental		26,905		25,641		24,380
	Corporate, All Other		624		572		500
		$	91,936	$	86,363	$	80,153

Schedule_V_Valuation_and_Quali

Schedule V - Valuation and Qualifying Accounts	12 Months Ended
	Dec. 31, 2014
Valuation and Qualifying Accounts [Abstract]
Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]		Balance at		Charged to				Balance at
		beginning of		costs and				end of
	Description	period		expenses		Deductions		period
	Year ended December 31, 2014:
	Allowance for Uncollectible Accounts Receivable	$	7,686		37,225		31,423	$	13,488
	Year ended December 31, 2013:
	Allowance for Uncollectible Accounts Receivable	$	55,163		24,256		71,733	$	7,686
	Year ended December 31, 2012:
	Allowance for Uncollectible Accounts Receivable	$	15,293		72,788		32,918	$	55,163

Accounting_Policies_by_Policy_

Accounting Policies, by Policy (Policies)	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation— The accompanying consolidated financial statements include the accounts of the Company and subsidiaries, each of which is wholly-owned, and have been prepared in conformity with GAAP. All intercompany accounts and balances have been eliminated in consolidation. The Company presents its financial statements to conform with Article 7 of the Securities and Exchange Commission Regulation S-X pursuant to Section 13-15(d) of the Securities Exchange Act of 1934.
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and Cash Equivalents— The Company defines cash as cash held in operating accounts at financial institutions. The Company considers highly liquid investments with maturities of three months or less at the date of acquisition as cash equivalents in the accompanying consolidated financial statements. These investments are carried at cost, which approximates fair value.
Investment, Policy [Policy Text Block]	Investments—The Company invests in certificates of deposit, corporate bonds and money market funds. The Company classifies all investments as available-for-sale. The Company engages a fixed income portfolio manager to manage the Company’s investment grade and non-investment grade corporate bonds, under the Company’s direction, in order to maximize investment returns. Such investments are recorded at fair value, with unrealized gains and losses recorded as a component of other comprehensive income. The Company recognizes gains and losses when these securities have other than temporary impairment, mature or are sold using the specific identification method.
	Management follows a consistent and systematic process for recognizing impairments on securities that sustain other-than-temporary declines in value. The decision to record an other-than-temporary impairment for a security incorporates both quantitative criteria and qualitative information. The Company considers the severity of the loss on a security, duration of loss, duration of the investment, credit rating of the security, as well as payment performance and the Company’s intent or requirement to sell the investment before recovery when determining whether any impairment is other than temporary. The Company’s impairment policy for fixed-maturity securities states that other-than-temporary impairment is considered to have occurred if (1) the Company intends to sell the impaired fixed maturity security; (2) it is more likely than not that the Company will be required to sell the fixed maturity security before recovery of its amortized cost basis; or (3) the present value of the expected cash flows is not sufficient to recover the entire amortized cost basis.
Property, Plant and Equipment, Policy [Policy Text Block]	Property and Equipment— Property and equipment is carried at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets. The building and the building improvements have useful lives of 27 years and 15 years, respectively. Furniture and fixtures have useful lives of 5 years, and computer equipment and software have useful lives of up to 5 years. Maintenance and repair costs are expensed as incurred. If an impairment exists, a loss is recorded as the amount by which the carrying value of the asset exceeds its fair value.
	The Company reviews property and equipment for impairment whenever events or changes in circumstances, such as significant decreases in market values of assets, changes in legal factors or in the business climate, and accumulation of costs significantly in excess of the amount originally expected to acquire or construct an asset, or other such factors indicate that the carrying amount may not be recoverable.
State Guarantee Fund Deposits [Policy Text Block]	State Guarantee Fund Deposits— The Company maintains funds on deposit with state insurance departments in those states where the Company is licensed to do business. These funds amounted to approximately $279,000 and $280,000 at December 31, 2014 and 2013, respectively. These funds are restricted and not available to the Company for normal operations and are included in other assets in the accompanying consolidated balance sheets.
Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]	Goodwill and Intangible Assets— Goodwill arises in business combinations when the purchase price of net assets less liabilities assumed acquired exceeds the fair value. As with tangible and other intangible assets, periodic impairment reviews are required, at least annually, as well as when events or circumstances change. Management uses judgment in assessing goodwill for impairment. Management reviews the recorded value of our goodwill annually, or sooner if events or changes in circumstances indicate that the carrying amount may exceed fair value. Professional judgment is exercised in determining future cash flows, timing and business valuation comparables or selecting discount rates to be used in any valuation assessments.
	Business acquisitions often result in recording identifiable intangible assets. Identifiable intangible assets are recognized at the time of an acquisition, based upon their fair value. Similar to long-lived tangible assets, identifiable intangible assets are subject to amortization and periodic impairment reviews whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The review for impairment of the Company’s intangible assets requires management to predict the estimated cash flows that will be generated by the long-lived asset over its remaining estimated useful life.
Deferred Policy Acquisition Costs, Policy [Policy Text Block]	Deferred Acquisition Costs— Deferred acquisition costs are those incremental direct costs related to the successful acquisition of new and renewal business. These incremental direct costs are those that are essential to the contract transaction and would not have been incurred had the contract transaction not occurred. Such incremental direct costs include commissions, costs of contract issuance and underwriting, premium taxes and other costs the Company incurs to acquire successful new business or renew existing business. The Company defers policy acquisition costs and amortizes them over the estimated life of the contracts, which are short-duration in nature, in proportion to premiums earned. The Company capitalized deferred acquisition costs of approximately $3,989,000, $4,867,000, and $3,368,000, and amortized approximately $4,129,000, $3,862,000, and $3,592,000 of these capitalized costs for the years ended December 31, 2014, 2013, and 2012, respectively. The amortization of these costs are recorded in commission expenses and other acquisition costs included in the consolidated statements of comprehensive income.
Redeemable Institutional Preferred Shares [Policy Text Block]	Redeemable Institutional Preferred Shares— In 2010, the Company entered into a Preferred Stock Purchase Agreement (the “2010-Stock Purchase Agreement”) with an investor. Pursuant to the 2010-Stock Purchase Agreement, the investor agreed to purchase 300 Shares at a purchase price of $1,000 per share, with an aggregate purchase price of $300,000. The annual dividend payable on each Share is 5% of the book value at the beginning of the dividend period.
	In 2012, the Company entered into a Preferred Shares Purchase Agreement (the “2012-Stock Purchase Agreement”) with an investor. Pursuant to the 2012-Stock Purchase Agreement, the investor agreed to purchase 1,000 shares of Redeemable Institutional Preferred Shares (the “2012 Preferred Shares”) at a purchase price of $1,000 per share, for an aggregate purchase price of $1,000,000. The annual dividend payable on each 2012 Preferred Share is 5% of the book value at the beginning of the dividend period.
	In 2013, the Company entered into a Preferred Shares Purchase Agreement (the “2013-Stock Purchase Agreement”) with an investor. Pursuant to the 2013-Stock Purchase Agreement, the investor agreed to purchase 1,000 shares of Redeemable Institutional Preferred Shares (the “2013 Preferred Shares”) at a purchase price of $1,000 per share, for an aggregate purchase price of $1,000,000. The annual dividend payable on each 2013 Preferred Share is 5% of the book value at the beginning of the dividend period.
	In the event of any liquidation, dissolution or winding up of the Company, any merger or consolidation resulting in a change of control of the Company, or any sale, lease, transfer or other disposition of substantially all of the assets of Company, holders of the Institutional Preferred Shares purchased pursuant to the 2012 and 2013-Stock Purchase Agreements will have the right to receive a cash payment in an amount equivalent to the consideration the investor would have otherwise received if the investor had the ability to convert each Preferred Share to 1.2 Class B Common Shares.
	Redeemable Institutional Preferred Shares are participating securities that share in total comprehensive income as a change to the redemption value of the redeemable Institutional Preferred Shares to accrete (dilute) the carrying value to the redemption value at the end of each reporting period. Under this method, the end of the reporting period is treated as if it were also the redemption date for the securities. Redeemable Institutional Preferred Shares are considered to be redeemable shares due to the fact that the shareholders have the option to require the Company to repurchase these shares upon the shareholder’s discretion.
Redeemable Common Shares [Policy Text Block]	Redeemable Common Shares— The Company’s Class A, Class B, and Class C redeemable common shares are owned by participating providers, Company directors, employees and non-dentist individuals. All participating providers, Company directors and Company employees are eligible to own the Class A and Class B voting redeemable common shares. Non-dentist individuals are eligible to own the Class C voting redeemable common shares. The maximum percentage of Class C Common Shares outstanding at any time as a proportion of all voting Common Shares is 40%. The Company’s Class A, Class B and Class C common shares are considered to be redeemable common shares due to the fact that the shareholders have the option to require the Company to repurchase these shares under certain circumstances. The Company records Class A, Class B and Class C common shares as Redeemable Common Shares in the consolidated balance sheets outside of shareholders’ equity at the redemption value of the common shares. Accordingly, the Company records total comprehensive income as a change to the redemption value of the Redeemable Common Shares to accrete (dilute) the carrying value of the Redeemable Common Shares to the redemption value at the end of each reporting period.  Under this method, the end of the reporting period is treated as if it were also the redemption date for the securities.
Insurance Premiums Revenue Recognition, Policy [Policy Text Block]	Premium Revenue—
	Fully-Insured—Membership contracts are written on an annual basis and are subject to cancellation by the employer group upon thirty days written notice. The Company’s unearned premium revenue was approximately $32,637,000 and $35,395,000 at December 31, 2014 and 2013, respectively, and primarily relates to the estimated premium revenue associated with the remaining contract periods. Related amounts recorded in accounts receivable were approximately $31,554,000 and $33,810,000 at December 31, 2014 and 2013, respectively. Premiums are due monthly in advance and are recognized evenly as revenue during the period in which the Company is obligated to provide services to members. Any amounts not received by the end of a reporting period are recorded as accounts receivable by the Company. Any premiums received prior to the beginning of a reporting period are recognized as premiums received in advance and are included in unearned premium revenue in the accompanying consolidated balance sheets. Premiums received in advance were approximately $1,083,000 and $1,585,000 at December 31, 2014 and 2013, respectively. Management has determined that as of December 31, 2014 and 2013, respectively, no premium deficiency reserve is required. The Company’s premium deficiency reserve analysis includes an allocation of investment income.
	Self-Insured—The Company provides administrative and claims processing services, benefit plan design, and access to its provider networks for an administrative fee to self-insured groups. The Company has no underwriting risk arising from the provision or cost of any services provided to the self-insured groups. The Company recognizes and records self-insured premiums on a gross basis because: (i) the Company is the primary obligor in its contractual relationships with self-insured employers and dental service providers, (ii) the Company establishes the pricing for the services provided, (iii) the Company controls the selection of and the relationships with the dental service providers, and (iv) the Company is involved in the determination of dental service specifications. Self-insured premium revenue is recognized upon the payment of claims for self-insured members in accordance with agreements with self-insured employers and is included in premium revenue in the accompanying condensed consolidated statements of comprehensive income.
	Third-party administration fee revenue (“ASO fees”) is recognized monthly when earned and is normally based on annual contracts with the self-insured groups. ASO fees are charged to self-insured employer groups monthly on a per subscriber per month basis. ASO fees also include the administrative fees the Company earns relative to the dental PPO, dental indemnity and vision products that are underwritten by third-party insurance carriers.
Investment Income [Policy Text Block]	Investment Income— Investment income is comprised of interest income primarily earned from the Company’s certificates of deposit, investment grade corporate bonds, non-investment grade corporate bonds, and money market investments.
Revenue Recognition other Income and Realized Gains on Investments Net [Policy Text Block]	Other Income and Realized Gains On Investments, Net — Other income is comprised primarily of rental income from the rental of space in the building owned and partially occupied by the Company (See Note 15).  Realized gains on investments is primarily made up of realized investment gains and losses from the sale of investment grade and non-investment grade corporate bonds.
Healthcare Services Expense [Policy Text Block]	Healthcare Services Expense— Healthcare services expense is recognized on a monthly basis. In the case of the fully-insured dental HMO and indemnity (“dental HMO/IND”) and dental PPO segments, healthcare services expense is calculated by taking the paid claims associated with the fully-insured membership and adjusting this amount for the change in the claims payable liability determined using actuarial estimates. For the self-insured dental segment, the healthcare services expense is based solely on the paid claims for the self-insured membership. The Company incurred claim costs related to dental care providers amounting to approximately $71,696,000, $67,762,000, and $63,736,000, for the years ended December 31, 2014, 2013, and 2012, respectively.
Unpaid Policy Claims and Claims Adjustment Expense, Policy [Policy Text Block]	Claims Payable— The Company estimates liabilities for both incurred but not reported (“IBNR”) and reported claims in process by employing actuarial methods that are commonly used by health insurance actuaries. These estimates meet actuarial standards of practice and are also recorded in accordance with GAAP. Management’s estimates of dental services provided are based on the Company’s historical experience and current trends, with assistance from the Company’s consulting actuary. Estimated dental claims payable are reviewed monthly by management and are adjusted based on current information, actual paid claims data, dental utilization statistics and other pertinent information. However, final claim payments may differ from the established reserves. Any resulting adjustments are reflected in current operations in the condensed consolidated statements of comprehensive income.
Reinsurance Accounting Policy [Policy Text Block]	Reinsurance— In the normal course of business, the Company assumes premium revenue and related healthcare services expense from a third party insurance provider. There was no dental insurance premium assumed for the year ended December 31, 2014. Dental insurance premium assumed was approximately $38,000 and $189,000, for the years ended December 31, 2013 and 2012, respectively. There was no healthcare services expense assumed for the year ended December 31, 2014. The healthcare services expense assumed was approximately $28,000 and $173,000 for the years ended December 31, 2013 and 2012, respectively. As of December 31, 2014, the Company had no reinsurance premium receivable or claims payable. As of December 31, 2013, the Company had approximately $1,000 of reinsurance premium receivable and claims payable of approximately $1,000.
Derivatives, Policy [Policy Text Block]	Derivative Instruments— All derivative financial instruments are recorded on the consolidated balance sheet at fair value. The changes in fair value of derivatives that are designated and qualify as cash flow hedges are recorded in other comprehensive income, with subsequent reclassification to earnings when the hedged transaction asset or liability impacts earnings. Any ineffectiveness is recognized in earnings immediately. The Company’s risk management policy is to not enter into derivatives for speculative purposes.
Income Tax, Policy [Policy Text Block]	Federal Income Tax— Deferred federal income tax is provided for in the accompanying consolidated financial statements for the tax effects of temporary differences between the carrying values and tax bases of assets and liabilities. Differences result primarily from items such as accrued commissions, deferred compensation, unearned premiums, property and equipment, deferred acquisition costs and unrealized gains on investments.
	The Company reviews the deferred tax assets to determine the necessity of a valuation allowance. Valuation allowances are provided to the extent it is more likely than not that deferred tax assets will not be realized. The Company files a consolidated federal income tax return which includes all subsidiaries.
Concentration Risk, Credit Risk, Policy [Policy Text Block]	Concentrations of Credit Risk— Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of premiums receivable. Other than as discussed below, concentrations of credit risk with respect to premiums receivable are limited because of the large number of employer groups comprising the Company’s client base and contracts are cancelled if premiums are not paid within 90 days.
	During 2014, 2013, and 2012, four fully-insured customers accounted for approximately 9%, 10%, and 9%, respectively, of the Company’s total revenue. Additionally, two self-insured customers accounted for approximately 11%, 11%, and 12% of the Company’s total revenue during each of the years 2014, 2013, and 2012, respectively.
	The Company had one customer that had a balance of approximately 23% and 29% of the uncollected premium receivable balance at December 31, 2014 and 2013, respectively.
	The Company maintains its cash in bank deposit accounts, which at times exceed federally insured limits. The Company has not experienced any losses in such accounts.
Fair Value of Financial Instruments, Policy [Policy Text Block]	Fair Value of Financial Instruments— Certain financial instruments are required to be recorded at fair value. The Company primarily bases fair value for investments in fixed-maturity securities (including federally-insured certificates of deposits, investment grade corporate bonds and non-investment grade corporate bonds) on quoted market prices or on prices from a pricing vendor, an outside resource that supplies securities pricing, dividend, corporate action and descriptive information to support pricing, securities operations, research and portfolio management. The Company obtains and reviews the pricing service’s valuation methodologies and validates these prices using various inputs, including quotes from other independent regulatory sources. When deemed necessary, the Company validates prices by replicating a sample using a discounted cash flow model. Changes in assumptions or estimation methods could affect the fair value estimates.

Note_3_Investments_Tables

Note 3 - Investments (Tables)	12 Months Ended
	Dec. 31, 2014
Investments, Debt and Equity Securities [Abstract]
Schedule of Maturity of Available-for-Sale Securities and Held-to-Maturity [Table Text Block]		Available-for-Sale
		Amortized		Fair		% of
		Cost		Value		Total Value
	31-Dec-14
	Maturity dates occurring:
	Less than 1 year (Three certificates of deposit)	$	700,000	$	704,676		8.5	%
	Greater than 1 year (Two certificates of deposit and 107 corporate bonds)		7,397,358		7,547,366		91.5	%
	Total	$	8,097,358	$	8,252,042		100	%
		Available-for-Sale
		Amortized		Fair		% of
		Cost		Value		Total Value
	31-Dec-13
	Maturity dates occurring:
	Less than 1 year (Two certificates of deposit)	$	200,000	$	201,027		2.8	%
	Greater than 1 year (Six certificates of deposit and 108 corporate bonds)		6,986,176		7,068,365		97.2	%
	Total	$	7,186,176	$	7,269,392		100	%
Schedule of Available-for-Sale Securities and Held-to-Maturity [Table Text Block]		Available-for-Sale
				Gross		Gross
		Amortized		Unrealized		Unrealized			Fair
		Cost		Gain		Loss			Value
	31-Dec-14
	Certificates of deposit, short term	$	700,000	$	4,676				$	704,676
	Certificates of deposit, fixed maturities		350,000		926					350,926
	Corporate bonds, fixed maturities		7,047,358		184,630	$	(35,548	)		7,196,440
	Total investments	$	8,097,358	$	190,232	$	(35,548	)	$	8,252,042
		Available-for-Sale
				Gross		Gross
		Amortized		Unrealized		Unrealized			Fair
		Cost		Gain		Loss			Value
	December 31, 2013
	Money market fund	$	60,217						$	60,217
	Certificates of deposit, short term		200,000	$	1,027					201,027
	Certificates of deposit, fixed maturities		1,050,000		8,693	$	(1,625	)		1,057,068
	Corporate bonds, fixed maturities		5,936,176		128,023		(52,902	)		6,011,297
	Total investments	$	7,246,393	$	137,743	$	(54,527	)	$	7,329,609

Note_4_Accumulated_Other_Compr1

Note 4 - Accumulated Other Comprehensive Income (Tables)	12 Months Ended
	Dec. 31, 2014
Disclosure Text Block [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]		2014									2013
		Before Tax			Income Tax			Net			Before Tax			Income Tax			Net
	Accumulated unrealized gains, net on investments available for sale, beginning of period	$	85,588		$	29,101		$	56,487		$	251,796		$	85,614		$	166,182
	Other comprehensive income (loss) before reclassification		99,917			33,974			65,943			(166,208	)		(56,513	)		(109,695	)
	Reclassification adjustment for realized investment gains (losses), net included in realized gains on investments, net		(29,691	)		(10,095	)		(19,596	)
	Effect on other comprehensive income (loss)		70,226			23,879			46,347			(166,208	)		(56,513	)		(109,695	)
	Accumulated unrealized gains, net, on investments available for sale, end of period	$	155,814		$	52,980		$	102,834		$	85,588		$	29,101		$	56,487
	Accumulated unrealized gains (losses), net, on interest rate swap, beginning of period	$	(55,618	)	$	(18,911	)	$	(36,707	)	$	(41,275	)	$	(14,034	)	$	(27,241	)
	Other comprehensive income before reclassification		50,764			17,260			33,504			(14,343	)		(4,877	)		(9,466	)
	Reclassification adjustment for realized interest swap loss, net included in realized gains on investments, net		-			-			-			-			-			-
	Effect on other comprehensive income (loss)		50,764			17,260			33,504			(14,343	)		(4,877	)		(9,466	)
	Accumulated unrealized gains, net, on interest rate swap, end of period	$	(4,854	)	$	(1,651	)	$	(3,203	)	$	(55,618	)	$	(18,911	)	$	(36,707	)
	Accumulated other comprehensive income, beginning of period	$	29,970		$	10,190		$	19,780		$	210,521		$	71,580		$	138,941
	Change in unrealized gains (losses), net, on investments available for sale		70,226			23,879			46,347			(166,208	)		(56,513	)		(109,695	)
	Change in unrealized gains (losses), net, on interest rate swap		50,764			17,260			33,504			(14,343	)		(4,877	)		(9,466	)
	Effect on other comprehensive income		120,990			41,139			79,851			(180,551	)		(61,390	)		(119,161	)
	Accumulated other comprehensive income, end of period	$	150,960		$	51,329		$	99,631		$	29,970		$	10,190		$	19,780
		2012
		Before Tax			Income Tax			Net
	Accumulated unrealized gains, net on investments available for sale, beginning of period	$	74,876		$	25,460		$	49,416
	Other comprehensive income (loss) before reclassification		217,225			73,856			143,369
	Reclassification adjustment for realized investment gains (losses), net included in realized gains on investments, net		(40,305	)		(13,702	)		(26,603	)
	Effect on other comprehensive income (loss)		176,920			60,154			116,766
	Accumulated unrealized gains, net, on investments available for sale, end of period	$	251,796		$	85,614		$	166,182
	Accumulated unrealized gains (losses), net, on interest rate swap, beginning of period	$	(16,354	)	$	(5,560	)	$	(10,794	)
	Other comprehensive income before reclassification		(30,821	)		(10,479	)		(20,342	)
	Reclassification adjustment for realized interest swap loss, net included in realized gains on investments, net		5,900			2,005			3,895
	Effect on other comprehensive income (loss)		(24,921	)		(8,474	)		(16,447	)
	Accumulated unrealized gains, net, on interest rate swap, end of period	$	(41,275	)	$	(14,034	)	$	(27,241	)
	Accumulated other comprehensive income, beginning of period	$	58,522		$	19,900		$	38,622
	Change in unrealized gains (losses), net, on investments available for sale		176,920			60,154			116,766
	Change in unrealized gains (losses), net, on interest rate swap		(24,921	)		(8,474	)		(16,447	)
	Effect on other comprehensive income		151,999			51,680			100,319
	Accumulated other comprehensive income, end of period	$	210,521		$	71,580		$	138,941

Note_5_Liability_for_Claims_Pa1

Note 5 - Liability for Claims Payable (Tables)	12 Months Ended
	Dec. 31, 2014
Liability For Claims Payable [Abstract]
Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]		2014		2013			2012
	Balance—January 1	$	2,219,725	$	2,136,010		$	2,801,468
	Net incurred claims related to:
	Current year		48,580,639		45,865,228			42,909,476
	Prior years		75,288		(146,287	)		(147,671	)
	Net incurred claims		48,655,927		45,718,941			42,761,805
	Net paid claims related to:
	Current year		45,587,042		43,648,282			40,775,534
	Prior years		2,290,997		1,986,944			2,651,729
	Net paid claims		47,878,039		45,635,226			43,427,263
	Balance—December 31	$	2,997,613	$	2,219,725		$	2,136,010

Note_6_Federal_Income_Taxes_Ta

Note 6 - Federal Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]		2014			2013			2012
	Current tax expense:
	Federal	$	1,020,061		$	811,632		$	973,336
	State and local		19,716			13,610			20,128
	Total current tax expense		1,039,777			825,242			993,464
	Deferred tax benefit
	Federal		(144,499	)		(64,374	)		(264,378	)
	State and local		(7,536	)		(6,029	)		(8,649	)
	Total deferred tax benefit		(152,035	)		(70,403	)		(273,027	)
	Total provision for income taxes	$	887,742		$	754,839		$	720,437
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]		2014			2013
	Deferred tax assets:
	Unearned premiums	$	73,616		$	107,785
	Net operating loss		33,404			37,490
	Recapitalization intangible		48,234			48,234
	Accrued vacation		66,998			74,228
	Accrued commissions		218,922			166,610
	Deferred compensation		940,593			701,346
	Accrued professional fees		46,342			43,282
	Other, net		52,042			40,796
	Gross deferred tax assets		1,480,151			1,219,771
	Valuation Allowance		(48,234	)		(48,234	)
	Gross deferred tax assets, net of valuation allowance		1,431,917			1,171,537
	Deferred tax liabilities:
	Unrealized gain on investments		51,326			10,192
	Deferred policy acquisition costs		101,684			111,355
	Prepaid insurance		70,772			66,154
	Property and equipment		122,119			3,503
	Identifiable intangible assets		27,571			32,790
	Gross deferred tax liabilities		373,472			223,994
	Net deferred tax asset	$	1,058,445		$	947,543
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]											2014			2013			2012
											Effective Tax			Effective Tax			Effective Tax
		2014			2013			2012			Rate			Rate			Rate
	Provision computed at statutory rate	$	757,831		$	692,391		$	693,074			34	%		34	%		34	%
	State and local taxes		4,575			2,954			4,864			0.2			0.1			0.2
	Nondeductible meals, entertainment and legal expense		11,603			9,453			8,815			0.5			0.5			0.4
	Nondeductible federal premium tax		113,733									5.1
	Valuation Allowance					48,243									2.4
	Other—net					1,798			13,684						0.1			0.7
	Provision for income taxes	$	887,742		$	754,839		$	720,437			39.8	%		37.1	%		35.3	%

Note_8_Property_and_Equipment_

Note 8 - Property and Equipment (Tables)	12 Months Ended
	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Table Text Block]		2014			2013
	Land	$	364,000		$	364,000
	Building and building improvements		2,494,601			2,435,101
	Furniture and equipment		2,787,159			2,402,545
	Total property and equipment		5,645,760			5,201,646
	Less accumulated depreciation	$	(2,968,846	)	$	(2,728,361	)
	Total property and equipment - net	$	2,676,914		$	2,473,285

Note_9_Deferred_Compensation_P1

Note 9 - Deferred Compensation Plan (Tables)	12 Months Ended
	Dec. 31, 2014
Compensation Related Costs [Abstract]
Schedule of Nonvested Share Activity [Table Text Block]		Individual Director's Share Awards			Weighted Average Grant Date Fair Value		Key Employee Share Awards			Fair Value at
										December 31,2014
	Non-vested awards at January 1, 2014							644.6
	Granted		252		$	894		295
	Vested		(252.0	)		894		(433.1	)
	Forfeited							(24.6	)
	Non-vested awards at December 31, 2014							481.9		$	1,018
		Individual Director's Share Awards			Weighted Average Grant Date Fair Value		Key Employee Share Awards			Fair Value at
										December 31,2013
	Non-vested awards at January 1, 2013							535.8
	Granted		252		$	886		204
	Vested during the year		(252.0	)		886		(74.2	)
	Forfeited							(21.0	)
	Non-vested awards at December 31, 2013							644.6		$	920
Schedule of Vested Share Activity [Table Text Block]		Individual Director's Awards			Weighted Average Vested price		Key Employee Awards			Fair Value at
										December 31,2014
	Vested awards at January 1, 2014		806.7		$	886		408.5
	Share based dividend		32.5			887		13.4
	Vested during the year		252			1,015		433.1
	Redeemed vested awards							(76.2	)
	Converted to Redeemable Common Shares		(252.0	)		1,015
	Vested awards at December 31, 2014		839.2			1,018		778.8		$	1,018
		Individual Director's Awards			Weighted Average Vested price		Key Employee Awards			Fair Value at December 31,2013
	Vested awards at January 1, 2013		876		$	815		339.7
	Share based dividend		34.5			828		13.4
	Vested during the year		252			881		74.2
	Redeemed vested awards		(103.8	)		794		(14.8	)
	Converted to Redeemable Common Shares		(252.0	)		881		(4.0	)
	Vested awards at December 31, 2013		806.7			886		408.5		$	920

Note_11_Debt_Tables

Note 11 - Debt (Tables)	12 Months Ended
	Dec. 31, 2014
Debt Disclosure [Abstract]
Schedule of Maturities of Long-term Debt [Table Text Block]	Years Ending
	31-Dec
	2015	$	49,200
	2016		50,400
	2017		52,800
	2018		55,200
	2019 and thereafter		1,040,000
	Total mortgage payable	$	1,247,600
Operating Leases of Lessee Disclosure [Table Text Block]	2015	$	268,595
	2016		249,638
	2017		146,979
	2018		137,929
	2019		11,462
	Total		814,603
	Less imputed interest		(43,125	)
	Present value of minimum lease payments	$	771,478

Note_14_Commitments_and_Contin1

Note 14 - Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	Years Ending
	31-Dec
	2015	$	156,000
	2016		126,000
	2017		46,000
	2018		36,000
	2019 and thereafter		17,000
	Total	$	381,000

Note_17_Segment_Information_Ta

Note 17 - Segment Information (Tables)	12 Months Ended
	Dec. 31, 2014
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment [Table Text Block]		Fiscal Year Ended						Fiscal Year Ended
		31-Dec-14						31-Dec-13
		Revenues-		Healthcare				Revenues-		Healthcare
		External		Services				External		Services
		Customers		Expense		Total		Customers		Expense		Total
	Reportable segments:
	Fully-insured dental HMO/Indemnity	$	47,948	$	35,995	$	11,953	$	46,656	$	35,024	$	11,632
	Fully-insured dental PPO		16,459		12,661		3,798		13,494		10,695		2,799
	Self-insured dental		26,905		23,040		3,865		25,641		22,043		3,598
	Corporate, all other		624				624		572				572
	Total	$	91,936	$	71,696		20,240	$	86,363	$	67,762		18,601
	Investment income						222						164
	Realized gains on investments, net						30
	Other income						62						61
	Insurance expense						18,325						16,790
	Income before income tax					$	2,229					$	2,036
	Total assets-corporate					$	57,239					$	56,903
		Fiscal Year Ended
		31-Dec-12
		Revenues-		Healthcare
		External		Services
		Customers		Expense		Total
	Reportable segments:
	Fully-insured dental HMO/Indemnity	$	43,844	$	33,399	$	10,445
	Fully-insured dental PPO		11,429		9,363		2,066
	Self-insured dental		24,380		20,974		3,406
	Corporate, all other		500				500
	Total	$	80,153	$	63,736		16,417
	Investment income						128
	Realized gains on investments, net						34
	Other income						68
	Insurance expense						14,609
	Income before income tax					$	2,038
	Total assets-corporate					$	37,337

Note_19_Fair_Value_Measurement1

Note 19 - Fair Value Measurements (Tables)	12 Months Ended
	Dec. 31, 2014
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]		31-Dec-14						31-Dec-13
		Level 1		Level 2		Total Balance		Level 1		Level 2		Total Balance
	Assets
	Fixed maturities
	Federally-Insured certificates of deposit			$	351	$	351			$	1,057	$	1,057
	Investment grade corporate bonds				6,780		6,780				6,011		6,011
	Non-investment grade corporate bonds				416		416
	Short-term investments
	Money Short-term investmentsmarket fund							$	60				60
	Federally-Insured certificates of deposit				705		705				201		201
	Deferred compensation investments (a)
	Equity mutual fund investments	$	530				530		419				419
	State guarantee fund deposits (b)
	Government securities		229				229		230				230
	Federally-Insured certificates of deposit				50		50				50		50
	Total	$	759	$	8,302	$	9,061	$	709	$	7,319	$	8,028
	Liabilities
	Interest rate swap (c)			$	5	$	5			$	56	$	56
	Total	$		$	5	$	5	$		$	56	$	56

Note_20_Quarterly_Data_Unaudit1

Note 20 - Quarterly Data (Unaudited) (Tables)	12 Months Ended
	Dec. 31, 2014
Quarterly Financial Information Disclosure [Abstract]
Schedule of Quarterly Financial Information [Table Text Block]		2014
		31-Mar		30-Jun		30-Sep		31-Dec		Total
	Premium revenue	$	22,636	$	22,851	$	23,578	$	22,871	$	91,936
	Gross profit		4,559		4,883		4,937		5,861		20,240
	Income before income taxes		195		363		882		789		2,229
		2013
		31-Mar		30-Jun		30-Sep		31-Dec		Total
	Premium revenue	$	20,849	$	21,415	$	22,614	$	21,485	$	86,363
	Gross profit		3,895		4,673		4,376		5,657		18,601
	Income before income taxes		140		581		188		1,127		2,036

Note_1_General_Information_and1

Note 1 - General Information and Summary of Significant Accounting Policies (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2010
Note 1 - General Information and Summary of Significant Accounting Policies (Details) [Line Items]
Number of Wholly Owned Subsidiaries	3
Number of Members Participate in Our Dental Benefits Plans	307,000
Number of Members Participating in our Vision Benefit Plans	$28,900
Number of Dentists Participating in our Dental HMO Network	2,808
Number of Dentists Participating in our Dental PPO Network	3,047
Number of Additional Dentists to which Company Can Access with in Companys Operating Territory	2,500
Number of Additional Dentists to which Company Can Access within Whole United States	42,700
State Insurance Department, Statutory to NAIC, Amount of Reconciling Item	279,000	280,000
Deferred Policy Acquisition Costs, Additions	3,989,000	4,867,000	3,368,000
Deferred Policy Acquisition Cost, Amortization Expense	4,129,000	3,862,000	3,592,000
Number of Shares Investor Agreed to Purchase under Stock Purchase Agreement		1,000
Purchase Price Per Share of Shares Agreed to Purchase under Stock Purchase Agreement (in Dollars per share)		$1,000	$1,000
Aggregate Purchase Price of Shares Agreed to Purchase under Stock Purchase Agreement		1,000,000	1,000,000
Preferred Stock, Dividend Rate, Percentage		5.00%	5.00%
Membership Contract Cancellation Duration	30 days
Financial Guarantee Insurance Contracts, Unearned Premium Revenue	32,637,000	35,395,000
Unbilled Contracts Receivable	31,554,000	33,810,000
Advance Premium Received	1,083,000	1,585,000
Premium Deficiency Reserve	0	0
Claim Costs Related to Dental Care Providers	71,696,000	67,762,000	63,736,000
Assumed Premiums Earned	0	38,000	189,000
Healthcare Service Expense Relating to Reinsurance		28,000	173,000
Reinsurance Receivables	0	1,000
Reinsurance Payable	0	1,000
Entity Wide Revenue Major Customer Fully Insured	4
Entity Wide Revenue Major Customer SelfInsured	2
Redeemable Institutional Preferred Shares [Member]
Note 1 - General Information and Summary of Significant Accounting Policies (Details) [Line Items]
Number of Shares Investor Agreed to Purchase under Stock Purchase Agreement			1,000	300
Purchase Price Per Share of Shares Agreed to Purchase under Stock Purchase Agreement (in Dollars per share)				$1,000
Aggregate Purchase Price of Shares Agreed to Purchase under Stock Purchase Agreement				$300,000
Preferred Stock, Dividend Rate, Percentage				5.00%
Building [Member]
Note 1 - General Information and Summary of Significant Accounting Policies (Details) [Line Items]
Property, Plant and Equipment, Useful Life	27 years
Building Improvements [Member]
Note 1 - General Information and Summary of Significant Accounting Policies (Details) [Line Items]
Property, Plant and Equipment, Useful Life	15 years
Furniture and Fixtures [Member]
Note 1 - General Information and Summary of Significant Accounting Policies (Details) [Line Items]
Property, Plant and Equipment, Useful Life	5 years
Computer Equipment and Software [Member]
Note 1 - General Information and Summary of Significant Accounting Policies (Details) [Line Items]
Property, Plant and Equipment, Useful Life	5 years
Four Customers [Member] | Sales Revenue, Net [Member] | Customer Concentration Risk [Member]
Note 1 - General Information and Summary of Significant Accounting Policies (Details) [Line Items]
Concentration Risk, Percentage	9.00%	10.00%	9.00%
Two Customers [Member] | Sales Revenue, Net [Member] | Customer Concentration Risk [Member]
Note 1 - General Information and Summary of Significant Accounting Policies (Details) [Line Items]
Concentration Risk, Percentage	11.00%	11.00%	12.00%
One Customer [Member] | Premium Receivable [Member] | Customer Concentration Risk [Member]
Note 1 - General Information and Summary of Significant Accounting Policies (Details) [Line Items]
Concentration Risk, Percentage	23.00%	29.00%

Note_2_Goodwill_and_Intangible1

Note 2 - Goodwill and Intangible Assets (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Note 2 - Goodwill and Intangible Assets (Details) [Line Items]
Goodwill	$136,000	$136,000
Goodwill, Impairment Loss	0
Finite-Lived Intangible Assets, Net	81,000	97,000
Finite-Lived Intangible Assets, Accumulated Amortization	159,000	143,000
Amortization of Intangible Assets	15,000	15,000	15,000
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	8 years
Finite-Lived Intangible Assets, Amortization Expense, Year Two	15,000
Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months	15,000
Provider Network [Member]
Note 2 - Goodwill and Intangible Assets (Details) [Line Items]
Finite-Lived Intangible Assets, Net	57,000
Finite-Lived Intangible Asset, Useful Life	20 years
Membership [Member]
Note 2 - Goodwill and Intangible Assets (Details) [Line Items]
Finite-Lived Intangible Assets, Net	$24,000
Finite-Lived Intangible Asset, Useful Life	11 years

Note_3_Investments_Details

Note 3 - Investments (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2012	Dec. 31, 2013
Note 3 - Investments (Details) [Line Items]
Available-for-sale Securities, Amortized Cost Basis	$7,397,000		$6,986,000
Available-for-sale Securities, Gross Realized Gain (Loss)	-10,095	-11,697
Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value	0		0
Federally-Insured Certificates of Deposit [Member]
Note 3 - Investments (Details) [Line Items]
Available-for-sale Securities, Amortized Cost Basis	1,050,000		1,200,000
Money Market Funds [Member]
Note 3 - Investments (Details) [Line Items]
Available-for-sale Securities			60,000
Investment Grade Corporate Bonds [Member] | A Minus or Better [Member]
Note 3 - Investments (Details) [Line Items]
Investment Owned, at Fair Value	5,247,000
Investment Grade Corporate Bonds [Member] | BBB+ and BBB- [Member]
Note 3 - Investments (Details) [Line Items]
Investment Owned, at Fair Value	1,949,000
Investment Grade Corporate Bonds [Member]
Note 3 - Investments (Details) [Line Items]
Available-for-sale Securities, Amortized Cost Basis	7,047,000		5,936,000
Investment Owned, at Fair Value	7,196,000
Weighted Average Yield to Book Value of Investment Grade Corporate Bonds	3.18%
Weighted Average Maturity of Investment	5 years 36 days
Available-for-sale Securities, Gross Realized Gain (Loss)	$30,000		$0

Note_3_Investments_Details_Mat

Note 3 - Investments (Details) - Maturity Dates for Fixed Maturities and Short-term Investments (USD $)	Dec. 31, 2014	Dec. 31, 2013
Maturity dates occurring:
Available-for-Sale Securities, Amortized Cost, Total	$7,397,000	$6,986,000
Certificates of Deposit [Member]
Maturity dates occurring:
Available-for-Sale Securities, Less than 1 year, Amortized Cost	700,000	200,000
Available-for-Sale Securities, Less than 1 year, Fair Value	704,676	201,027
Available-for-Sale Securities, Less than 1 year, Percentage	8.50%	2.80%
Available-for-Sale Securities, Greater than 1 year, Amortized Cost	7,397,358	6,986,176
Available-for-Sale Securities, Greater than 1 year, Fair Value	7,547,366	7,068,365
Available-for-Sale Securities, Greater than 1 year, Percentage	91.50%	97.20%
Available-for-Sale Securities, Amortized Cost, Total	8,097,358	7,186,176
Available-for-Sale Securities, Fair Value Total	$8,252,042	$7,269,392
Available-for-Sale Securities, Percentage, Total	100.00%	100.00%

Note_3_Investments_Details_Inv

Note 3 - Investments (Details) - Investments as Fixed Maturities and Short-term Investments (USD $)	Dec. 31, 2014	Dec. 31, 2013
Note 3 - Investments (Details) - Investments as Fixed Maturities and Short-term Investments [Line Items]
Available-for-Sale, Amortized Cost	$8,097,358	$7,246,393
Available-for-Sale, Gross Unrealized Gain	190,232	137,743
Available-for-Sale, Gross Unrealized Loss	-35,548	-54,527
Available-for-Sale, Fair Value	8,252,042	7,329,609
Certificates of Deposit, Short-term [Member]
Note 3 - Investments (Details) - Investments as Fixed Maturities and Short-term Investments [Line Items]
Available-for-Sale, Amortized Cost	700,000	200,000
Available-for-Sale, Gross Unrealized Gain	4,676	1,027
Available-for-Sale, Fair Value	704,676	201,027
Certificates of Deposit, Fixed Maturities [Member]
Note 3 - Investments (Details) - Investments as Fixed Maturities and Short-term Investments [Line Items]
Available-for-Sale, Amortized Cost	350,000	1,050,000
Available-for-Sale, Gross Unrealized Gain	926	8,693
Available-for-Sale, Gross Unrealized Loss		-1,625
Available-for-Sale, Fair Value	350,926	1,057,068
Corporate Bonds, Fixed Maturities [Member]
Note 3 - Investments (Details) - Investments as Fixed Maturities and Short-term Investments [Line Items]
Available-for-Sale, Amortized Cost	7,047,358	5,936,176
Available-for-Sale, Gross Unrealized Gain	184,630	128,023
Available-for-Sale, Gross Unrealized Loss	-35,548	-52,902
Available-for-Sale, Fair Value	7,196,440	6,011,297
Money Market Funds [Member]
Note 3 - Investments (Details) - Investments as Fixed Maturities and Short-term Investments [Line Items]
Available-for-Sale, Amortized Cost		60,217
Available-for-Sale, Fair Value		$60,217

Note_4_Accumulated_Other_Compr2

Note 4 - Accumulated Other Comprehensive Income (Details) - Change in Unrealized Gains and Losses on Available-for-sale Securities in AOCI (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated unrealized gains, before taxes at period start	$29,970	$210,521	$58,522
Accumulated unrealized gains, taxes at period start	10,190	71,580	19,900
Accumulated unrealized gains, net, at period start	19,780	138,941	38,622
Reclassification adjustment from accumulated other comprehensive income, net	19,596		22,708
Effect on other comprehensive income (loss), before tax	120,990	-180,551	151,999
Effect on other comprehensive income (loss), tax	41,139	-61,390	51,680
Effect on other comprehensive income (loss), net	79,851	-119,161	100,319
Accumulated unrealized gains, before taxes at period end	150,960	29,970	210,521
Accumulated unrealized gains, taxes at period end	51,329	10,190	71,580
Accumulated unrealized gains, net, at period end	99,631	19,780	138,941
Accumulated Unrealized Gains Net on Investments Available-for-sale [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated unrealized gains, before taxes at period start	85,588	251,796	74,876
Accumulated unrealized gains, taxes at period start	29,101	85,614	25,460
Accumulated unrealized gains, net, at period start	56,487	166,182	49,416
Change in unrealized gains (losses), before tax	70,226	-166,208	176,920
Change in unrealized gains (losses), tax	23,879	-56,513	60,154
Change in unrealized gains (losses), net	46,347	-109,695	116,766
Other comprehensive income (loss) before reclassification, before tax	99,917	-166,208	217,225
Other comprehensive income (loss) before reclassification, tax	33,974	-56,513	73,856
Other comprehensive income (loss) before reclassification, net	65,943	-109,695	143,369
Reclassification adjustment from accumulated other comprehensive income, before tax	-29,691		-40,305
Reclassification adjustment from accumulated other comprehensive income, tax	-10,095		-13,702
Reclassification adjustment from accumulated other comprehensive income, net	-19,596		-26,603
Effect on other comprehensive income (loss), before tax	70,226	-166,208	176,920
Effect on other comprehensive income (loss), tax	23,879	-56,513	60,154
Effect on other comprehensive income (loss), net	46,347	-109,695	116,766
Accumulated unrealized gains, before taxes at period end	155,814	85,588	251,796
Accumulated unrealized gains, taxes at period end	52,980	29,101	85,614
Accumulated unrealized gains, net, at period end	102,834	56,487	166,182
Accumulated Unrealized Losses, Net, on Interest Rate Swaps [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated unrealized gains, before taxes at period start	-55,618	-41,275	-16,354
Accumulated unrealized gains, taxes at period start	-18,911	-14,034	-5,560
Accumulated unrealized gains, net, at period start	-36,707	-27,241	-10,794
Change in unrealized gains (losses), before tax	50,764	-14,343	-24,921
Change in unrealized gains (losses), tax	17,260	-4,877	-8,474
Change in unrealized gains (losses), net	33,504	-9,466	-16,447
Other comprehensive income (loss) before reclassification, before tax	50,764	-14,343	-30,821
Other comprehensive income (loss) before reclassification, tax	17,260	-4,877	-10,479
Other comprehensive income (loss) before reclassification, net	33,504	-9,466	-20,342
Reclassification adjustment from accumulated other comprehensive income, before tax			5,900
Reclassification adjustment from accumulated other comprehensive income, tax			2,005
Reclassification adjustment from accumulated other comprehensive income, net			3,895
Effect on other comprehensive income (loss), before tax	50,764	-14,343	-24,921
Effect on other comprehensive income (loss), tax	17,260	-4,877	-8,474
Effect on other comprehensive income (loss), net	33,504	-9,466	-16,447
Accumulated unrealized gains, before taxes at period end	-4,854	-55,618	-41,275
Accumulated unrealized gains, taxes at period end	-1,651	-18,911	-14,034
Accumulated unrealized gains, net, at period end	($3,203)	($36,707)	($27,241)

Note_5_Liability_for_Claims_Pa2

Note 5 - Liability for Claims Payable (Details) - Activity in Liability for Claims Payable for Members (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Activity in Liability for Claims Payable for Members [Abstract]
Balance—January 1	$2,219,725	$2,136,010	$2,801,468
Net incurred claims related to:
Current year	48,580,639	45,865,228	42,909,476
Prior years	75,288	-146,287	-147,671
Net incurred claims	48,655,927	45,718,941	42,761,805
Net paid claims related to:
Current year	45,587,042	43,648,282	40,775,534
Prior years	2,290,997	1,986,944	2,651,729
Net paid claims	47,878,039	45,635,226	43,427,263
Balance—December 31	$2,997,613	$2,219,725	$2,136,010

Note_6_Federal_Income_Taxes_De

Note 6 - Federal Income Taxes (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Note 6 - Federal Income Taxes (Details) [Line Items]
Operating Loss Carryforwards	$98,247	$110,265	$122,544

Note_6_Federal_Income_Taxes_De1

Note 6 - Federal Income Taxes (Details) - Components of Provision (Benefit) for Income Taxes (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Current tax expense:
Federal	$1,020,061	$811,632	$973,336
State and local	19,716	13,610	20,128
Total current tax expense	1,039,777	825,242	993,464
Deferred tax benefit
Federal	-144,499	-64,374	-264,378
State and local	-7,536	-6,029	-8,649
Total deferred tax benefit	-152,035	-70,403	-273,027
Total provision for income taxes	$887,742	$754,839	$720,437

Note_6_Federal_Income_Taxes_De2

Note 6 - Federal Income Taxes (Details) - Deferred Tax Assets and Liabilities (USD $)	Dec. 31, 2014	Dec. 31, 2013
Deferred tax assets:
Unearned premiums	$73,616	$107,785
Net operating loss	33,404	37,490
Recapitalization intangible	48,234	48,234
Accrued vacation	66,998	74,228
Accrued commissions	218,922	166,610
Deferred compensation	940,593	701,346
Accrued professional fees	46,342	43,282
Other, net	52,042	40,796
Gross deferred tax assets	1,480,151	1,219,771
Valuation Allowance	-48,234	-48,234
Gross deferred tax assets, net of valuation allowance	1,431,917	1,171,537
Deferred tax liabilities:
Unrealized gain on investments	51,326	10,192
Deferred policy acquisition costs	101,684	111,355
Prepaid insurance	70,772	66,154
Property and equipment	122,119	3,503
Identifiable intangible assets	27,571	32,790
Gross deferred tax liabilities	373,472	223,994
Net deferred tax asset	$1,058,445	$947,543

Note_6_Federal_Income_Taxes_De3

Note 6 - Federal Income Taxes (Details) - Reconciliation of Effective Tax Rate (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Reconciliation of Effective Tax Rate [Abstract]
Provision computed at statutory rate	$757,831	$692,391	$693,074
Provision computed at statutory rate	34.00%	34.00%	34.00%
State and local taxes	4,575	2,954	4,864
State and local taxes	0.20%	0.10%	0.20%
Nondeductible meals, entertainment and legal expense	11,603	9,453	8,815
Nondeductible meals, entertainment and legal expense	0.50%	0.50%	0.40%
Nondeductible federal premium tax	113,733
Nondeductible federal premium tax	5.10%
Valuation Allowance		48,243
Valuation Allowance		2.40%
Other—net		1,798	13,684
Other—net		0.10%	0.70%
Provision for income taxes	$887,742	$754,839	$720,437
Provision for income taxes	39.80%	37.10%	35.30%

Note_7_Accounting_for_Uncertai1

Note 7 - Accounting for Uncertain Tax Positions (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Accounting For Uncertain Tax Positions [Abstract]
Unrecognized Tax Benefits	$0	$0	$0

Note_8_Property_and_Equipment_1

Note 8 - Property and Equipment (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Property, Plant and Equipment [Abstract]
Depreciation	$318,000	$347,000	$271,000

Note_8_Property_and_Equipment_2

Note 8 - Property and Equipment (Details) - Property and Equipment (USD $)	Dec. 31, 2014	Dec. 31, 2013
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$5,645,760	$5,201,646
Less accumulated depreciation	-2,968,846	-2,728,361
Total property and equipment - net	2,676,914	2,473,285
Land [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	364,000	364,000
Building and Building Improvements [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	2,494,601	2,435,101
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$2,787,159	$2,402,545

Note_9_Deferred_Compensation_P2

Note 9 - Deferred Compensation Plan (Details) (USD $)	12 Months Ended			1 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Feb. 28, 2014	Feb. 28, 2013
Note 9 - Deferred Compensation Plan (Details) [Line Items]
Percentage of Director's Award Vest On Meeting Certain Attendance Requirements	100.00%
Percentage of Key Employee Awards Vest in Year One Following Grant Date	10.00%
Percentage of Key Employee Awards Vest in Year Two Following Grant Date	20.00%
Percentage of Key Employee Awards Vest in Year Three Following Grant Date	30.00%
Percentage of Key Employee Awards Vest in Year Four Following Grant Date	40.00%
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options	$301,000
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition	1 year 124 days
Dividends Payable, Amount Per Share (in Dollars per share)				$35.77	$32.60
Increase (Decrease) in Deferred Compensation	959,380	675,195	542,630
Share Based Compensation Arrangement by Share Based Payment Award Number of Shares Granted	3,293
Class B Redeemable Common Shares [Member]
Note 9 - Deferred Compensation Plan (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in Shares)	15,000
Director Fees and Employee Compensation [Member]
Note 9 - Deferred Compensation Plan (Details) [Line Items]
Deferred Compensation Arrangement with Individual, Compensation Expense	130,000	67,000	88,000
Deferred Share and Phantom Shares [Member]
Note 9 - Deferred Compensation Plan (Details) [Line Items]
Deferred Compensation Arrangement with Individual, Compensation Expense	872,000	616,000	466,000
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation	296,000	209,000	158,000
Stock Compensation Plan [Member] | Directors and Employees [Member]
Note 9 - Deferred Compensation Plan (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares (in Shares)	145	165
Stock Compensation Plan [Member] | Long Term Incentive Plan [Member]
Note 9 - Deferred Compensation Plan (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares (in Shares)	337	480
Dividend Declared [Member]
Note 9 - Deferred Compensation Plan (Details) [Line Items]
Increase (Decrease) in Deferred Compensation				$41,000	$52,000
Maximum [Member]
Note 9 - Deferred Compensation Plan (Details) [Line Items]
Long Term Incentive Compensation Program Executive Officers, Percentage of Base Salaries	45.00%
Non Employee [Member]
Note 9 - Deferred Compensation Plan (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in Shares)	252
Key Employee [Member]
Note 9 - Deferred Compensation Plan (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in Shares)	295	204

Note_9_Deferred_Compensation_P3

Note 9 - Deferred Compensation Plan (Details) - Activity of Non-vested Awards (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Director [Member]
Note 9 - Deferred Compensation Plan (Details) - Activity of Non-vested Awards [Line Items]
Granted	252	252
Granted (in Dollars per share)	$894	$886
Vested	-252	-252
Vested (in Dollars per share)	$894	$886
Key Employee [Member]
Note 9 - Deferred Compensation Plan (Details) - Activity of Non-vested Awards [Line Items]
Non-vested awards at period start	644.6	535.8
Granted	295	204
Vested	-433.1	-74.2
Forfeited	-24.6	-21
Non-vested awards at period end	481.9	644.6
Non-vested awards at period end (in Dollars per share)	$1,018	$920

Note_9_Deferred_Compensation_P4

Note 9 - Deferred Compensation Plan (Details) - Activity of Vested Awards (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Director [Member]
Note 9 - Deferred Compensation Plan (Details) - Activity of Vested Awards [Line Items]
Vested awards at period start	806.7	876
Vested awards at period start (in Dollars per share)	$886	$815
Share based dividend	32.5	34.5
Share based dividend (in Dollars per share)	$887	$828
Vested during the year	252	252
Vested during the year (in Dollars per share)	$1,015	$881
Redeemed vested awards		-103.8
Redeemed vested awards (in Dollars per share)		$794
Converted to Redeemable Common Shares	-252	-252
Converted to Redeemable Common Shares (in Dollars per share)	$1,015	$881
Vested awards at period end	839.2	806.7
Vested awards at period end (in Dollars per share)	$1,018	$886
Key Employee [Member]
Note 9 - Deferred Compensation Plan (Details) - Activity of Vested Awards [Line Items]
Vested awards at period start	408.5	339.7
Vested awards at period start (in Dollars per share)	$920
Share based dividend	13.4	13.4
Vested during the year	433.1	74.2
Redeemed vested awards	-76.2	-14.8
Converted to Redeemable Common Shares		-4
Vested awards at period end	778.8	408.5
Vested awards at period end (in Dollars per share)	$1,018	$920

Note_10_Redeemable_Shares_Shar1

Note 10 - Redeemable Shares, Shareholders' Equity and Dividend Restrictions (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2010
Note 10 - Redeemable Shares, Shareholders' Equity and Dividend Restrictions (Details) [Line Items]
Common Stock, Value, Subscriptions	$997	$894
Common Stock, Dividends, Per Share, Declared (in Dollars per share)	$35.77	$32.60	$21
Preferred Stock, Shares Authorized (in Shares)	92,700	92,700		100,000
Preferred Stock, Shares Issued (in Shares)	0	0
Preferred Stock, Dividend Rate, Percentage		5.00%	5.00%
Dividends	-425,327	-392,196	-244,103
Dividends, Preferred Stock	128,000	123,000	83,000
Statutory Accounting Practices, Statutory Amount Available for Dividend Payments without Regulatory Approval	969,000
Net Income (Loss) Attributable to Parent	1,341,173	1,281,606	1,318,017
Investor [Member] | Institutional Preferred Shares-2010 Series [Member]
Note 10 - Redeemable Shares, Shareholders' Equity and Dividend Restrictions (Details) [Line Items]
Preferred Stock, Shares Issued (in Shares)		1,000	1,000	300
Share Price (in Dollars per share)		$1,000	$1,000	1,000
Common Class C [Member]
Note 10 - Redeemable Shares, Shareholders' Equity and Dividend Restrictions (Details) [Line Items]
Class of Stock, Percentage of Voting Common Shares	40.00%
Class D Redeemable Common Shares [Member]
Note 10 - Redeemable Shares, Shareholders' Equity and Dividend Restrictions (Details) [Line Items]
Common Stock, Shares Authorized (in Shares)	100,000
Preferred Stock, Shares Authorized (in Shares)	100,000	100,000
Preferred Stock, Shares Issued (in Shares)	0	0
Institutional Preferred Shares-2010 Series [Member]
Note 10 - Redeemable Shares, Shareholders' Equity and Dividend Restrictions (Details) [Line Items]
Preferred Stock, Shares Authorized (in Shares)	300	300
Preferred Stock, Shares Issued (in Shares)	300	300
Preferred Stock, Dividend Rate, Percentage	5.00%
Dividends	128,000	123,000	67,000
Provider Preferred-2009 Series [Member]
Note 10 - Redeemable Shares, Shareholders' Equity and Dividend Restrictions (Details) [Line Items]
Preferred Stock, Shares Authorized (in Shares)	5,000	5,000
Preferred Stock, Shares Issued (in Shares)	0	0
Preferred Stock, Dividend Rate, Percentage		5.00%
Dental Care Plus [Member]
Note 10 - Redeemable Shares, Shareholders' Equity and Dividend Restrictions (Details) [Line Items]
Dental Insurance Subsidiary Dividend as Percentage of Net Worth	10.00%
Dental Insurance Subsidiary Net Worth Maximum Amount	250,000
Dividends, Common Stock	0	0
Proceeds from Dividends Received			360,000
Net Income (Loss) Attributable to Parent	1,156,000	1,191,000	1,108,000
Net Worth	$9,689,000	$8,560,000

Note_11_Debt_Details

Note 11 - Debt (Details) (USD $)	1 Months Ended	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Note 11 - Debt (Details) [Line Items]
Proceeds from Issuance of Secured Debt	$1,340,000			$1,340,000
Secured Debt	1,340,000	1,247,600	1,294,400	1,340,000
Debt Instrument, Maturity Date				22-Dec-22
Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate	3.90%			3.90%
Reference Rate Maturity Duration				10 years
Minimum Net Worth Required for Compliance	3,500,000	2,500,000	2,500,000	3,500,000
Sale Leaseback Transaction, Gross Proceeds, Financing Activities		516,000	312,000
Repayments of Debt and Capital Lease Obligations		552,000	327,000
Sale Lease-back Transaction Period		4 years	3 years
Mortgages [Member]
Note 11 - Debt (Details) [Line Items]
Debt Service Ratio				1
London Interbank Offered Rate (LIBOR) [Member]
Note 11 - Debt (Details) [Line Items]
Debt Instrument, Basis Spread on Variable Rate	1.95%
Estimate of Fair Value Measurement [Member]
Note 11 - Debt (Details) [Line Items]
Secured Debt	$1,247,600			$1,247,600

Note_11_Debt_Details_Principal

Note 11 - Debt (Details) - Principal Repayments Under Mortgage Loan Payable (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Principal Repayments Under Mortgage Loan Payable [Abstract]
2015	$49,200
2016	50,400
2017	52,800
2018	55,200
2019 and thereafter	1,040,000
Total mortgage payable	$1,247,600	$1,294,400	$1,340,000

Note_11_Debt_Details_Future_Pa

Note 11 - Debt (Details) - Future Payments Under Outstanding Capital Leases (USD $)	Dec. 31, 2014
Future Payments Under Outstanding Capital Leases [Abstract]
2015	$268,595
2016	249,638
2017	146,979
2018	137,929
2019	11,462
Total	814,603
Less imputed interest	-43,125
Present value of minimum lease payments	$771,478

Note_12_Derivative_Details

Note 12 - Derivative (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2003
Note 12 - Derivative (Details) [Line Items]
Derivative Asset, Notional Amount			$1,340,000
Derivative, Maturity Date			22-Dec-22
Derivative Interest Rate Period			30 days
Reference Rate Maturity Duration			10 years
Derivative, Fair Value, Net	5,000	56,000
Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax	33,504	-9,466	-20,342
Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax	17,260	-4,877	-10,479
Interest Rate Swap [Member] | Maximum [Member]
Note 12 - Derivative (Details) [Line Items]
Derivative, Notional Amount			1,800,000
Interest Rate Swap [Member]
Note 12 - Derivative (Details) [Line Items]
Derivative, Lower Fixed Interest Rate Range			1.75%
Derivative, Higher Fixed Interest Rate Range			4.95%
Derivative, Notional Amount				1,500,000
Derivative, Loss on Derivative			5,900
Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax	33,504	-9,466	-16,447
Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax	$17,260	($4,877)	($8,474)
Minimum [Member]
Note 12 - Derivative (Details) [Line Items]
Derivative, Lower Fixed Interest Rate Range			1.95%
Maximum [Member]
Note 12 - Derivative (Details) [Line Items]
Derivative, Higher Fixed Interest Rate Range			3.90%

Note_13_Lines_of_Credit_Detail

Note 13 - Lines of Credit (Details) (USD $)	12 Months Ended		1 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Note 13 - Lines of Credit (Details) [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	500,000
Long-term Line of Credit	0	0
Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate			3.90%
Working Capital Line Of Credit One [Member] | London Interbank Offered Rate (LIBOR) [Member]
Note 13 - Lines of Credit (Details) [Line Items]
Debt Instrument, Basis Spread on Variable Rate	2.50%
Working Capital Line Of Credit One [Member]
Note 13 - Lines of Credit (Details) [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	1,000,000
Long-term Line of Credit	0	0
Financing Interest Expense		0
Line of Credit [Member] | London Interbank Offered Rate (LIBOR) [Member]
Note 13 - Lines of Credit (Details) [Line Items]
Debt Instrument, Basis Spread on Variable Rate	2.50%
Line of Credit [Member]
Note 13 - Lines of Credit (Details) [Line Items]
Financing Interest Expense	0
Letter of Credit [Member] | Prime Rate [Member]
Note 13 - Lines of Credit (Details) [Line Items]
Debt Instrument, Basis Spread on Variable Rate	6.00%
Letter of Credit [Member]
Note 13 - Lines of Credit (Details) [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	10,000
Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate	2.10%
London Interbank Offered Rate (LIBOR) [Member]
Note 13 - Lines of Credit (Details) [Line Items]
Debt Instrument, Basis Spread on Variable Rate			1.95%

Note_14_Commitments_and_Contin2

Note 14 - Commitments and Contingencies (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Commitments and Contingencies Disclosure [Abstract]
Operating Leases, Rent Expense	$154,000	$136,000	$118,000

Note_14_Commitments_and_Contin3

Note 14 - Commitments and Contingencies (Details) - Future Approximate Minimum Annual Lease Payments Under Non-Cancelable Operating Leases (USD $)	Dec. 31, 2014
Future Approximate Minimum Annual Lease Payments Under Non-Cancelable Operating Leases [Abstract]
2015	$156,000
2016	126,000
2017	46,000
2018	36,000
2019 and thereafter	17,000
Total	$381,000

Note_15_Lease_Income_Details

Note 15 - Lease Income (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Lease Income [Abstract]
Operating Leases, Income Statement, Lease Revenue	$62,000	$62,000	$68,000
Operating Leases, Future Minimum Payments Receivable, Current	$62,000

Note_16_Retirement_Plan_Detail

Note 16 - Retirement Plan (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Disclosure Text Block Supplement [Abstract]
Defined Contribution Plan, Employers Matching Contribution, Vesting Period	5 years
Defined Contribution Plan, Employer Discretionary Contribution Amount	$60,000	$60,000	$60,000

Note_17_Segment_Information_De

Note 17 - Segment Information (Details) (USD $)	3 Months Ended								12 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Note 17 - Segment Information (Details) [Line Items]
Number of Reportable Segments									4
Gross Profit	$5,861,000	$4,937,000	$4,883,000	$4,559,000	$5,657,000	$4,376,000	$4,673,000	$3,895,000	$20,240,000	$18,601,000
Corporate, Non-Segment [Member]
Note 17 - Segment Information (Details) [Line Items]
Gross Profit									$20,240,000	$18,601,000	$16,417,000

Note_17_Segment_Information_De1

Note 17 - Segment Information (Details) - Reportable Segment (USD $)	3 Months Ended								12 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Reportable segments:
Reportable segments, Revenues- External Customers	$22,871,000	$23,578,000	$22,851,000	$22,636,000	$21,485,000	$22,614,000	$21,415,000	$20,849,000	$91,936,578	$86,362,613	$80,153,437
Reportable segments, Healthcare Services Expense									71,695,797	67,762,332	63,735,583
Reportable segments, Total									20,240,000	18,601,000	16,417,000
Investment income									221,622	164,057	128,412
Realized gains on investments, net									29,691		34,046
Other income									62,304	61,477	67,926
Insurance expense									18,325,483	16,789,370	14,609,784
Income before income tax	789,000	882,000	363,000	195,000	1,127,000	188,000	581,000	140,000	2,228,915	2,036,445	2,038,454
Total assets-corporate	57,238,810				56,903,105				57,238,810	56,903,105	37,337,000
Fully-insured dental HMO/Indemnity [Member]
Reportable segments:
Reportable segments, Revenues- External Customers									47,948,000	46,656,000	43,844,000
Reportable segments, Healthcare Services Expense									35,995,000	35,024,000	33,399,000
Reportable segments, Total									11,953,000	11,632,000	10,445,000
Fully Insured Dental PPO [Member]
Reportable segments:
Reportable segments, Revenues- External Customers									16,459,000	13,494,000	11,429,000
Reportable segments, Healthcare Services Expense									12,661,000	10,695,000	9,363,000
Reportable segments, Total									3,798,000	2,799,000	2,066,000
Self-insured Dental [Member]
Reportable segments:
Reportable segments, Revenues- External Customers									26,905,000	25,641,000	24,380,000
Reportable segments, Healthcare Services Expense									23,040,000	22,043,000	20,974,000
Reportable segments, Total									3,865,000	3,598,000	3,406,000
Corporate and Other [Member]
Reportable segments:
Reportable segments, Revenues- External Customers									624,000	572,000	500,000
Reportable segments, Total									$624,000	$572,000	$500,000

Note_18_Related_Parties_Detail

Note 18 - Related Parties (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Note 18 - Related Parties (Details) [Line Items]
Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims	$48,655,927	$45,718,941	$42,761,805
Liability for Claims and Claims Adjustment Expense	2,997,613	2,219,725	2,136,010	2,801,468
Noninterest Expense Directors Fees	191,000	154,000	159,000
Shareholders [Member]
Note 18 - Related Parties (Details) [Line Items]
Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims	36,902,000	37,566,000	37,720,000
Liability for Claims and Claims Adjustment Expense	$1,547,000	$1,231,000

Note_19_Fair_Value_Measurement2

Note 19 - Fair Value Measurements (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Note 19 - Fair Value Measurements (Details) [Line Items]
Assets, Fair Value Disclosure, Nonrecurring	$0	$0
Liabilities, Fair Value Disclosure, Nonrecurring	0	0
Assets, Fair Value Disclosure	9,061	8,028
Financial and Nonfinancial Liabilities, Fair Value Disclosure	5	56
Fair Value, Inputs, Level 3 [Member]
Note 19 - Fair Value Measurements (Details) [Line Items]
Assets, Fair Value Disclosure	0	0
Financial and Nonfinancial Liabilities, Fair Value Disclosure	$0	$0

Note_19_Fair_Value_Measurement3

Note 19 - Fair Value Measurements (Details) - Assets and Liabilities Measured at Fair Value on a Recurring Basis (USD $)	Dec. 31, 2014		Dec. 31, 2013
In Thousands, unless otherwise specified
Fixed maturities
Assets	$9,061		$8,028
Liabilities
Liabilities	5		56
Fixed Maturities [Member] | Federally-Insured Certificates of Deposit [Member] | Fair Value, Inputs, Level 2 [Member]
Fixed maturities
Assets	351		1,057
Fixed Maturities [Member] | Federally-Insured Certificates of Deposit [Member]
Fixed maturities
Assets	351		1,057
Fixed Maturities [Member] | Investment Grade Corporate Bonds [Member] | Fair Value, Inputs, Level 2 [Member]
Fixed maturities
Assets	6,780		6,011
Fixed Maturities [Member] | Investment Grade Corporate Bonds [Member]
Fixed maturities
Assets	6,780		6,011
Fixed Maturities [Member] | Non-Investment Grade Corporate Bonds [Member] | Fair Value, Inputs, Level 2 [Member]
Fixed maturities
Assets	416
Fixed Maturities [Member] | Non-Investment Grade Corporate Bonds [Member]
Fixed maturities
Assets	416
Short-term Investments [Member] | Federally-Insured Certificates of Deposit [Member] | Fair Value, Inputs, Level 2 [Member]
Fixed maturities
Assets	705		201
Short-term Investments [Member] | Federally-Insured Certificates of Deposit [Member]
Fixed maturities
Assets	705		201
Short-term Investments [Member] | Fair Value, Inputs, Level 1 [Member] | Money Market Funds [Member]
Fixed maturities
Assets			60
Short-term Investments [Member] | Money Market Funds [Member]
Fixed maturities
Assets			60
Deferred Compensation Investment [Member] | Equity Mutual Fund Investments [Member] | Fair Value, Inputs, Level 1 [Member]
Fixed maturities
Assets	530	[1]	419	[1]
Deferred Compensation Investment [Member] | Equity Mutual Fund Investments [Member]
Fixed maturities
Assets	530	[1]	419	[1]
State Guarantee Fund Deposits [Member] | US Government Agencies Debt Securities [Member] | Fair Value, Inputs, Level 1 [Member]
Fixed maturities
Assets	229	[2]	230	[2]
State Guarantee Fund Deposits [Member] | US Government Agencies Debt Securities [Member]
Fixed maturities
Assets	229	[2]	230	[2]
State Guarantee Fund Deposits [Member] | Federally-Insured Certificates of Deposit [Member] | Fair Value, Inputs, Level 2 [Member]
Fixed maturities
Assets	50	[2]	50	[2]
State Guarantee Fund Deposits [Member] | Federally-Insured Certificates of Deposit [Member]
Fixed maturities
Assets	50	[2]	50	[2]
Fair Value, Inputs, Level 1 [Member]
Fixed maturities
Assets	759		709
Fair Value, Inputs, Level 2 [Member] | Interest Rate Swap [Member]
Liabilities
Liabilities	5	[3]	56	[3]
Fair Value, Inputs, Level 2 [Member]
Fixed maturities
Assets	8,302		7,319
Liabilities
Liabilities	5		56
Interest Rate Swap [Member]
Liabilities
Liabilities	$5	[3]	$56	[3]
[1]	Included as a trading security in other assets
[2]	Included in other assets
[3]	Included in other payables and accruals

Note_20_Quarterly_Data_Unaudit2

Note 20 - Quarterly Data (Unaudited) (Details) - Unaudited Quarterly Results of Operations (USD $)	3 Months Ended								12 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Unaudited Quarterly Results of Operations [Abstract]
Premium revenue	$22,871,000	$23,578,000	$22,851,000	$22,636,000	$21,485,000	$22,614,000	$21,415,000	$20,849,000	$91,936,578	$86,362,613	$80,153,437
Gross profit	5,861,000	4,937,000	4,883,000	4,559,000	5,657,000	4,376,000	4,673,000	3,895,000	20,240,000	18,601,000
Income before income taxes	$789,000	$882,000	$363,000	$195,000	$1,127,000	$188,000	$581,000	$140,000	$2,228,915	$2,036,445	$2,038,454

Note_21_Subsequent_Events_Deta

Note 21 - Subsequent Events (Details) (USD $)	12 Months Ended	60 Months Ended
	Dec. 31, 2014	Dec. 31, 2019	Feb. 28, 2014	Feb. 28, 2013	Feb. 11, 2015	Jan. 31, 2015
Note 21 - Subsequent Events (Details) [Line Items]
Annual Assessment on all Health Insurers	$11,300,000,000
Federal Premium Tax Assessment, Exemption Limit	25,000,000
Federal Premium Tax Rate	50.00%
Dividends Payable, Amount Per Share (in Dollars per share)			$35.77	$32.60
Class A Redeemable Common Shares [Member] | Subsequent Event [Member]
Note 21 - Subsequent Events (Details) [Line Items]
Dividends Payable, Amount Per Share (in Dollars per share)					$39.86
Class B Redeemable Common Shares [Member] | Subsequent Event [Member]
Note 21 - Subsequent Events (Details) [Line Items]
Dividends Payable, Amount Per Share (in Dollars per share)					$39.86
Class C Redeemable Common Shares [Member] | Subsequent Event [Member]
Note 21 - Subsequent Events (Details) [Line Items]
Dividends Payable, Amount Per Share (in Dollars per share)					$39.86
Subsequent Event [Member]
Note 21 - Subsequent Events (Details) [Line Items]
Deferred Tax Liabilities, Net, Current						530,000
Scenario, Forecast [Member]
Note 21 - Subsequent Events (Details) [Line Items]
Annual Assessment on all Health Insurers		16,000,000,000
Minimum [Member]
Note 21 - Subsequent Events (Details) [Line Items]
Federal Premium Tax Assessment, Range Amount	25,000,000
Maximum [Member]
Note 21 - Subsequent Events (Details) [Line Items]
Federal Premium Tax Assessment, Range Amount	$50,000,000

Schedule_I_Summary_of_Investme1

Schedule I - Summary of Investments - Other Than Investments in Relate Parties (Details) - Investments - Other Than Investments in Related Parties (USD $)	Dec. 31, 2014	Dec. 31, 2013
Bonds:
Amortized Cost	$7,397,000	$6,986,000
Fair Value	8,252,042	7,329,609
Corporate Debt Securities [Member] | Subsidiaries [Member]
Bonds:
Amortized Cost	7,047,000
Fair Value	7,196,000
Balance Sheet	7,196,000
Certificates of Deposit, Short-term [Member] | Investments [Member] | Subsidiaries [Member]
Bonds:
Amortized Cost	1,050,000
Fair Value	1,056,000
Balance Sheet	1,056,000
Subsidiaries [Member]
Bonds:
Amortized Cost	8,097,000
Fair Value	8,252,000
Balance Sheet	$8,252,000

Schedule_II_Condensed_Financia1

Schedule II - Condensed Financial Information of Registrant (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Schedule II - Condensed Financial Information of Registrant (Details) [Line Items]
Income Taxes Paid, Net	$1,270,000	$540,000	$1,110,000
Parent [Member]
Schedule II - Condensed Financial Information of Registrant (Details) [Line Items]
Payments to Acquire Real Estate Held-for-investment			1,886,000
Dental Benefit, Expense	107,000	92,000	80,000
Adenta, Inc. [Member]
Schedule II - Condensed Financial Information of Registrant (Details) [Line Items]
Cash Dividends Paid to Parent Company by Unconsolidated Subsidiaries	$150,000	$0

Schedule_II_Condensed_Financia2

Schedule II - Condensed Financial Information of Registrant (Details) - Condensed Financial Information of Registrant Condensed Balance Sheets (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
INVESTMENTS:
Fixed maturities	$7,547,366	$7,068,365
Short-term investments	704,676	261,244
Total investments	8,252,042	7,329,609
CASH AND CASH EQUIVALENTS	9,189,994	8,105,859	8,530,758	6,976,358
ACCRUED INVESTMENT INCOME	69,462	53,287
PROPERTY	2,676,914	2,473,285
OTHER ASSETS	2,423,916	2,220,582
TOTAL ASSETS	57,238,810	56,903,105	37,337,000
OTHER PAYABLES AND ACCRUALS	5,444,808	5,445,258
MORTGAGE LOAN PAYABLE	1,247,600	1,294,400	1,340,000
DEFERRED COMPENSATION	2,766,449	2,062,783
TOTAL LIABILITIES	45,864,716	46,796,768
REDEEMABLE SHARES:
TOTAL LIABILITIES, REDEEMABLE SHARES AND SHAREHOLDERS' EQUITY	57,238,810	56,903,105
Institutional Preferred Shares-2010 Series [Member] | Parent Company [Member]
REDEEMABLE SHARES:
Redeemable shares	414,173	391,814
Institutional Preferred Shares-2010 Series [Member]
REDEEMABLE SHARES:
Redeemable shares	414,173	391,814
Institutional Preferred Shares-2012 Series [Member] | Parent Company [Member]
REDEEMABLE SHARES:
Redeemable shares	1,195,484	1,130,946
Institutional Preferred Shares-2012 Series [Member]
REDEEMABLE SHARES:
Redeemable shares	1,195,484	1,130,946
Institutional Preferred Shares-2013 Series [Member] | Parent Company [Member]
REDEEMABLE SHARES:
Redeemable shares	1,099,604	1,040,242
Institutional Preferred Shares-2013 Series [Member]
REDEEMABLE SHARES:
Redeemable shares	1,099,604	1,040,242
Class A Redeemable Common Shares [Member] | Parent Company [Member]
REDEEMABLE SHARES:
Redeemable shares	529,158	488,282
Class A Redeemable Common Shares [Member]
REDEEMABLE SHARES:
Redeemable shares	529,158	488,282
Class B Redeemable Common Shares [Member] | Parent Company [Member]
REDEEMABLE SHARES:
Redeemable shares	7,815,789	7,055,053
Class B Redeemable Common Shares [Member]
REDEEMABLE SHARES:
Redeemable shares	7,815,789	7,055,053
Class C Redeemable Common Shares [Member] | Parent Company [Member]
REDEEMABLE SHARES:
Redeemable shares	319,886
Class C Redeemable Common Shares [Member]
REDEEMABLE SHARES:
Redeemable shares	319,886
Class D Redeemable Common Shares [Member] | Parent Company [Member]
REDEEMABLE SHARES:
Redeemable shares	0	0
Class D Redeemable Common Shares [Member]
REDEEMABLE SHARES:
Redeemable shares	0	0
Provider Preferred-2009 Series [Member] | Parent Company [Member]
REDEEMABLE SHARES:
Redeemable shares	0	0
Provider Preferred-2009 Series [Member]
REDEEMABLE SHARES:
Redeemable shares	0	0
Parent Company [Member]
INVESTMENTS:
Fixed maturities	926,182	877,671
Short-term investments		41,738
Total investments	926,182	919,409
CASH AND CASH EQUIVALENTS	1,831,520	1,375,743	1,135,718	524,732
ACCRUED INVESTMENT INCOME	11,165	4,349
INTERCOMPANY RECEIVABLES	572,005	373,829
INTERCOMPANY NOTE RECEIVABLE	230,000	230,000
PROPERTY	1,854,933	1,907,474
INVESTMENT IN SUBSIDIARIES	10,269,275	9,333,447	8,155,857
DEFERRED INCOME TAX	1,045,723	811,976
OTHER ASSETS	789,431	690,855
TOTAL ASSETS	17,530,234	15,647,082
OTHER PAYABLES AND ACCRUALS	2,142,091	2,183,562
MORTGAGE LOAN PAYABLE	1,247,600	1,294,400
DEFERRED COMPENSATION	2,766,449	2,062,783
TOTAL LIABILITIES	6,156,140	5,540,745
REDEEMABLE SHARES:
Redeemable shares	11,374,094	10,106,337
SHAREHOLDERS’ EQUITY—Preferred Shares; no par value—authorized, 92,700 shares; issued, none	0	0
TOTAL LIABILITIES, REDEEMABLE SHARES AND SHAREHOLDERS' EQUITY	$17,530,234	$15,647,082

Schedule_II_Condensed_Financia3

Schedule II - Condensed Financial Information of Registrant (Details) - Condensed Financial Information of Registrant Condensed Balance Sheets (Parentheticals) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2010
Condensed Balance Sheet Statements, Captions [Line Items]
Preferred shares, authorized	92,700	92,700	100,000
Institutional Preferred Shares-2010 Series [Member] | Parent Company [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Redeemable shares, par value (in Dollars per share)	0	0
Redeemable shares, cumulative dividend	5.00%	5.00%
Redeemable shares, authorized	300	300
Redeemable shares, issued	300	300
Redeemable shares, outstanding	300	300
Preferred shares, par value (in Dollars per share)	0	0
Institutional Preferred Shares-2010 Series [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Redeemable shares, cumulative dividend	5.00%	5.00%
Preferred shares, authorized	300	300
Preferred shares, issued	300	300
Institutional Preferred Shares-2012 Series [Member] | Parent Company [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Redeemable shares, par value (in Dollars per share)	0	0
Redeemable shares, cumulative dividend	5.00%	5.00%
Redeemable shares, authorized	1,000	1,000
Redeemable shares, issued	1,000	1,000
Redeemable shares, outstanding	1,000	1,000
Preferred shares, par value (in Dollars per share)	0	0
Institutional Preferred Shares-2012 Series [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Redeemable shares, cumulative dividend	5.00%	5.00%
Preferred shares, authorized	1,000	1,000
Preferred shares, issued	1,000	1,000
Institutional Preferred Shares-2013 Series [Member] | Parent Company [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Redeemable shares, par value (in Dollars per share)	0	0
Redeemable shares, cumulative dividend	5.00%	5.00%
Redeemable shares, authorized	1,000	1,000
Redeemable shares, issued	1,000	1,000
Redeemable shares, outstanding	1,000	1,000
Preferred shares, par value (in Dollars per share)	0	0
Institutional Preferred Shares-2013 Series [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Redeemable shares, cumulative dividend	5.00%	5.00%
Preferred shares, authorized	1,000	1,000
Preferred shares, issued	1,000	1,000
Class A Redeemable Common Shares [Member] | Parent Company [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Redeemable shares, par value (in Dollars per share)	0	0
Redeemable shares, authorized	7,500	7,500
Redeemable shares, issued	531	546
Redeemable shares, outstanding	531	546
Preferred shares, par value (in Dollars per share)	0	0
Class A Redeemable Common Shares [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Redeemable shares, authorized	7,500	7,500
Redeemable shares, issued	531	546
Redeemable shares, outstanding	531	546
Class B Redeemable Common Shares [Member] | Parent Company [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Redeemable shares, par value (in Dollars per share)	0	0
Redeemable shares, authorized	120,000	120,000
Redeemable shares, issued	7,843	7,889
Redeemable shares, outstanding	7,843	7,889
Preferred shares, par value (in Dollars per share)	0	0
Class B Redeemable Common Shares [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Redeemable shares, authorized	120,000	120,000
Redeemable shares, issued	7,843	7,889
Redeemable shares, outstanding	7,843	7,889
Class C Redeemable Common Shares [Member] | Parent Company [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Redeemable shares, par value (in Dollars per share)	0	0
Redeemable shares, authorized	80,000	80,000
Redeemable shares, issued	321	0
Redeemable shares, outstanding	321	0
Preferred shares, par value (in Dollars per share)	0	0
Class C Redeemable Common Shares [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Preferred shares, authorized	80,000	80,000
Preferred shares, issued	321	0
Class D Redeemable Common Shares [Member] | Parent Company [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Redeemable shares, par value (in Dollars per share)	0	0
Redeemable shares, authorized	100,000	100,000
Preferred shares, par value (in Dollars per share)	0	0
Class D Redeemable Common Shares [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Preferred shares, authorized	100,000	100,000
Provider Preferred-2009 Series [Member] | Parent Company [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Redeemable shares, par value (in Dollars per share)	0	0
Redeemable shares, cumulative dividend	5.00%	5.00%
Redeemable shares, authorized	5,000	5,000
Redeemable shares, issued	0	0
Preferred shares, par value (in Dollars per share)	0	0
Provider Preferred-2009 Series [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Redeemable shares, cumulative dividend	5.00%	5.00%
Preferred shares, authorized	5,000	5,000
Parent Company [Member]
Condensed Balance Sheet Statements, Captions [Line Items]
Redeemable shares, par value (in Dollars per share)	0	0
Preferred shares, par value (in Dollars per share)	0	0
Preferred shares, authorized	92,700	92,700
Preferred shares, issued	0	0

Schedule_II_Condensed_Financia4

Schedule II - Condensed Financial Information of Registrant (Details) - Condensed Financial Information of Registrant Condensed Statements of Comprehensive Income (USD $)	3 Months Ended								12 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
REVENUES
Investment income									$221,622	$164,057	$128,412
Total revenues									92,250,195	86,588,147	80,383,821
Insurance expense:
Salaries and benefit expense									7,249,590	6,534,300	5,523,969
Other insurance expense									5,952,103	6,180,356	5,206,212
Total expenses									90,021,280	84,551,702	78,345,367
INCOME BEFORE INCOME TAX	789,000	882,000	363,000	195,000	1,127,000	188,000	581,000	140,000	2,228,915	2,036,445	2,038,454
PROVISION (BENEFIT) FOR INCOME TAX:
Current									1,039,777	825,242	993,464
Deferred									-152,035	-70,403	-273,027
Total									887,742	754,839	720,437
NET INCOME									1,341,173	1,281,606	1,318,017
Change in the fair value of interest rate swap									33,504	-9,466	-20,342
Change in the fair value of investments									65,943	-109,695	143,369
Total other comprehensive income held by subsidaries									79,851	-119,161	100,319
TOTAL COMPREHENSIVE INCOME									1,421,024	1,162,445	1,418,336
Parent Company [Member]
REVENUES
Management fees from subsidiaries									11,486,781	11,029,944	9,531,143
Investment income									33,528	16,536	7,502
Administrative fees									798,900	713,915	273,251
Total revenues									12,319,209	11,760,395	9,811,896
Insurance expense:
Salaries and benefit expense									7,356,679	6,626,586	5,603,918
Other insurance expense									4,470,223	5,043,160	3,956,496
Total expenses									11,826,902	11,669,746	9,560,414
INCOME BEFORE INCOME TAX									492,307	90,649	251,482
PROVISION (BENEFIT) FOR INCOME TAX:
Current									428,152	226,519	284,933
Deferred									-246,426	-134,903	-187,044
Total									181,726	91,616	97,889
Income (Loss) before undistributed income of subsidiaries									310,581	-967	153,593
Undistributed income of subsidiaries									1,030,592	1,282,573	1,164,424
NET INCOME									1,341,173	1,281,606	1,318,017
Change in the fair value of interest rate swap											6,900
Change in the fair value of investments									74,832	-104,983	143,369
Reclassification adjustment for gains included in undistributed income									-19,596		-22,708
Total other comprehensive income held by subsidaries									55,236	-104,983	127,561
Change in the fair value of investments									-8,889	-4,712
Change in the fair value of interest rate swap									33,504	-9,466	-27,242
TOTAL COMPREHENSIVE INCOME									$1,421,024	$1,162,445	$1,418,336

Schedule_II_Condensed_Financia5

Schedule II - Condensed Financial Information of Registrant (Details) - Condensed Financial Information of Registrant Condensed Statements of Cash Flows (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$1,341,173	$1,281,606	$1,318,017
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	335,230	360,024	288,261
Loss on disposal of property		56,495
Deferred income (benefit) tax	-152,035	-70,403	-273,027
Deferred compensation	959,380	675,195	542,630
Effects of changes in operating assets and liabilities:
Accrued investment income	-16,175	-20,369	6,746
Other assets	-104,083	-195,397	-1,018
Other payables and accruals	109,840	1,376,415	-84,275
Net cash provided by operating activities	2,556,959	2,695,878	1,362,065
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of investments	-2,629,082	-4,174,475	-1,166,660
Acquisition of property and equipment	-530,245	-600,844	-124,222
Acquisition of property from subsidiary	1,802,603	1,089,504	1,075,042
Net cash used in investing activities	-845,330	-3,378,860	-255,840
CASH FLOWS FROM FINANCING ACTIVITIES:
Mortgage loan repayments	-46,800	-45,600	-780,000
Borrowing of mortgage note			1,340,000
Repurchase of redeemable shares	-361,721	-264,031	-137,891
Issuance of redeemable shares	330,535	1,096,959	1,044,245
Dividends paid	-425,327	-392,196	-260,426
Net cash (used in) provided by financing activities	-627,494	258,083	448,175
INCREASE IN CASH	1,084,135	-424,899	1,554,400
CASH AND CASH EQUIVALENTS—Beginning of year	8,105,859	8,530,758	6,976,358
CASH AND CASH EQUIVALENTS—End of year	9,189,994	8,105,859	8,530,758
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for interest	59,000	56,000	46,000
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Redeemed common shares (in other payables and accruals)	82,518	130,219	160,024
Deferred restricted shares units issued in lieu of cash dividend	40,712	52,042	28,210
Parent Company [Member]
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	1,341,173	1,281,606	1,318,017
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	116,194	110,567
Loss on disposal of property		56,495
Undistributed income of subsidiaries	-1,030,592	-1,282,573	-1,164,424
Deferred income (benefit) tax	-246,426	-134,903	-187,044
Deferred compensation	959,380	675,195	542,630
Effects of changes in operating assets and liabilities:
Accrued investment income	-6,816	-4,349
Intercompany accounts receivables	-198,176	34,003	-403,074
Other assets	-89,141	-151,936	5,839
Other payables and accruals	56,994	339,117	684,596
Net cash provided by operating activities	902,590	923,222	796,540
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of investments	-822,222	-885,902
Sale and maturities of investments	794,972
Acquisition of property and equipment	-61,250	-187,427
Acquisition of property from subsidiary			-1,886,004
Investment, other	-5,000	-5,000	-40,000
Net cash used in investing activities	-93,500	-1,078,329	-1,926,004
CASH FLOWS FROM FINANCING ACTIVITIES:
Mortgage loan repayments	-46,800	-45,600
Borrowing of mortgage note			1,340,000
Advance to subsidiaries			-605,478
Dividends from subsidiaries to finance real estate	150,000		360,000
Repurchase of redeemable shares	-361,721	-264,031	-137,891
Issuance of redeemable shares	330,535	1,096,959	1,044,245
Dividends paid	-425,327	-392,196	-260,426
Net cash (used in) provided by financing activities	-353,313	395,132	1,740,450
INCREASE IN CASH	455,777	240,025	610,986
CASH AND CASH EQUIVALENTS—Beginning of year	1,375,743	1,135,718	524,732
CASH AND CASH EQUIVALENTS—End of year	1,831,520	1,375,743	1,135,718
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for interest	47,000	52,000
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Redeemed common shares (in other payables and accruals)	82,518	130,219	160,024
Redeemed common shares issued in lieu of cash payment of deferred compensation	255,714	225,522	125,902
Deferred restricted shares units issued in lieu of cash dividend	$40,712	$52,042	$28,210
Class A redeemable common shares exchanged for Class B redeemable common shares (in Shares)		5,672	9,819

Schedule_II_Condensed_Financia6

Schedule II - Condensed Financial Information of Registrant (Details) - Reconciliation of Investment in Subsidiaries (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Total other comprehensive income held by subsidiaries	$79,851	($119,161)	$100,319
Parent Company [Member]
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Investment in Subsidiaries—January 1	9,333,447	8,155,857
Investment in Subsidiaries—December 31	10,269,275	9,333,447	8,155,857
Undistributed income of subsidiaries	1,030,592	1,282,573	1,164,424
Total other comprehensive income held by subsidiaries	55,236	-104,983	127,561
Dividends from subsidiaries to finance real estate	-150,000		-360,000
Increase in Investment in Subsidiary	$935,828	$1,177,590

Schedule_III_Supplementary_Ins1

Schedule III - Supplementary Insurance Information (Details) - Supplementary Insurance Information (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014		Dec. 31, 2013		Dec. 31, 2012
Schedule III - Supplementary Insurance Information (Details) - Supplementary Insurance Information [Line Items]
Deferred policy acquisition cost (a)	$2,050	[1]	$2,190	[1]	$1,184	[1]
Claims payable (a)	2,998	[1]	2,220	[1]	2,136	[1]
Unearned premium (a)	32,637	[1]	35,395	[1]	19,792	[1]
Other policy claims and benefits payable (a)	3,229		3,088		2,105
Premium revenues
Premium revenues	91,936		86,363		80,153
Investment income (a)	222	[1]	164	[1]	128	[1]
Future policy benefits, losses, claims and expense losses
Future policy benefits, losses, claims and expense losses	71,696		67,762		63,736
Amortization of deferred policy acquisition cost (a)	4,129		3,862		3,592
Other operating expense (a)	14,196	[1]	12,928	[1]	11,018	[1]
Fully-insured dental HMO/Indemnity [Member]
Premium revenues
Premium revenues	47,948		46,656		43,844
Future policy benefits, losses, claims and expense losses
Future policy benefits, losses, claims and expense losses	35,995		35,024		33,399
Fully Insured Dental [Member]
Premium revenues
Premium revenues	16,459		13,494		11,429
Future policy benefits, losses, claims and expense losses
Future policy benefits, losses, claims and expense losses	12,661		10,695		9,363
Premium written
Fully-insured dental (a)	62,151	[1]	75,363	[1]	52,650	[1]
Self-insured Dental [Member]
Premium revenues
Premium revenues	26,905		25,641		24,380
Future policy benefits, losses, claims and expense losses
Future policy benefits, losses, claims and expense losses	23,040		22,043		20,974
Corporate and Other [Member]
Premium revenues
Premium revenues	$624		$572		$500
[1]	The Company does not allocate insurance expense, investment and other income, or other assets or liabilities to identified segments.

Schedule_IV_Reinsurance_Detail

Schedule IV - Reinsurance (Details) - Reinsurance (USD $)	3 Months Ended								12 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Gross earned premium amounts
Gross earned premium amounts									$91,936,000	$86,325,000	$79,964,000
Assumed amounts from other companies
Assumed amounts from other companies									0	38,000	189,000
Net earned premium amounts
Net earned premium amounts	22,871,000	23,578,000	22,851,000	22,636,000	21,485,000	22,614,000	21,415,000	20,849,000	91,936,578	86,362,613	80,153,437
Fully-insured dental HMO/Indemnity [Member]
Gross earned premium amounts
Gross earned premium amounts									47,948,000	46,656,000	43,844,000
Ceded earned premium amounts to other companies
Ceded earned premium amounts to other companies									0	0	0
Assumed amounts from other companies
Assumed amounts from other companies									0	0	0
Net earned premium amounts
Net earned premium amounts									47,948,000	46,656,000	43,844,000
Fully Insured Dental [Member]
Gross earned premium amounts
Gross earned premium amounts									16,459,000	13,456,000	11,240,000
Ceded earned premium amounts to other companies
Ceded earned premium amounts to other companies									0	0	0
Assumed amounts from other companies
Assumed amounts from other companies										38,000	189,000
Net earned premium amounts
Net earned premium amounts									16,459,000	13,494,000	11,429,000
Self-insured Dental [Member]
Gross earned premium amounts
Gross earned premium amounts									26,905,000	25,641,000	24,380,000
Ceded earned premium amounts to other companies
Ceded earned premium amounts to other companies									0	0	0
Assumed amounts from other companies
Assumed amounts from other companies									0	0	0
Net earned premium amounts
Net earned premium amounts									26,905,000	25,641,000	24,380,000
Corporate and Other [Member]
Gross earned premium amounts
Gross earned premium amounts									624,000	572,000	500,000
Ceded earned premium amounts to other companies
Ceded earned premium amounts to other companies									0	0	0
Assumed amounts from other companies
Assumed amounts from other companies									0	0	0
Net earned premium amounts
Net earned premium amounts									$624,000	$572,000	$500,000

Schedule_V_Valuation_and_Quali1

Schedule V - Valuation and Qualifying Accounts (Details) - Valuation and Qualifying Accounts (Allowance for Trade Receivables [Member], USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Allowance for Trade Receivables [Member]
Valuation Allowance [Line Items]
Balance at beginning of period	$7,686	$55,163	$15,293
Charged to costs and expenses	37,225	24,256	72,788
Deductions	31,423	71,733	32,918
Balance at end of period	$13,488	$7,686	$55,163

Uncategorized_Items

Uncategorized Items
[us-gaap_CommonStockSharesOutstanding]	596	7,827	300
[us-gaap_StockholdersEquity]				409,211	5,378,383	342,464